Medical Nursing

Medical Nursing related content

Pheochromocytoma

Pheochromocytoma

Pheochromocytoma 

Pheochromocytoma is a tumor that produces excessive amounts of catecholamines, including adrenaline (epinephrine) and noradrenaline (norepinephrine). 

Pheochromocytoma is a type of neuroendocrine tumor that grows from cells called chromaffin cells. These cells produce hormones needed for the body and are found in the adrenal glands.

It is usually benign but can be malignant in some cases.

 

Pheochromocytomas can occur at any age but are commonly diagnosed in adults between the ages of 30 and 50. 

Pathophysiology 

Pheochromocytomas arise from chromaffin cells, which are specialized cells in the adrenal medulla that produce and release catecholamines into the bloodstream. In pheochromocytoma, there is uncontrolled and excessive secretion of catecholamines, leading to episodic or sustained hypertension(high blood pressure). The excess catecholamines can stimulate adrenergic receptors in various organs and tissues, resulting in a wide range of symptoms. 

Effects on Blood Pressure: 

Catecholamines have potent effects on blood vessels and the heart. They can cause vasoconstriction, leading to elevated blood pressure. They can increase heart rate and cardiac contractility, further contributing to elevated blood pressure.

Clinical Presentation of Pheochromocytoma

Clinical Presentation of Pheochromocytoma

Pheochromocytomas can cause a variety of symptoms, often due to the excessive release of catecholamines (epinephrine and norepinephrine). These symptoms can be sporadic or persistent.

Common Signs and Symptoms:

  • Headaches: Often severe and can be throbbing.
  • Sweating (Hyperhidrosis): Profuse and generalized sweating episodes.
  • Tachycardia: A rapid or racing heartbeat. Palpitations may also be present.
  • Hypertension: High blood pressure, which can be sustained or occur in sudden spikes (paroxysmal hypertension).
  • Pallor: A pale face, often accompanying episodes of high blood pressure.
  • Nausea and Vomiting: Feeling sick to the stomach.
  • Anxiety and Panic: Feelings of intense anxiety, nervousness, and impending doom.
  • Tremor: Shakiness or trembling, often in the hands.
  • Agitation: Feeling restless, irritable, and uneasy.
  • Chest Pain or Discomfort: May mimic angina.

Less Common Symptoms:

  • Visual Disturbances: Blurred vision.
  • Abdominal Pain: Less frequent, but possible.
  • Constipation: Due to the effects of catecholamines on the digestive system.
  • Weight Loss: Unexplained weight loss can occur.
  • Hyperglycemia: High blood sugar.
  • Orthostatic Hypotension: Drop in blood pressure upon standing.
  • Seizures: In rare cases, very high blood pressure can lead to seizures.

Diagnosis and Investigations:

History and Physical Examination: A careful medical history, focusing on symptom onset, duration, and severity, is crucial. Physical examination may reveal signs of hypertension, tachycardia, and tremor.

Biochemical Testing:

  • Plasma and Urine Catecholamine Levels: Measurement of epinephrine, norepinephrine, and metanephrines (breakdown products of catecholamines) in plasma and urine is the primary diagnostic tool.
  • Plasma Free Metanephrines: This test is highly sensitive and specific for pheochromocytoma.

Imaging Studies:

  • Abdominal Computed Tomography (CT) Scan: Used to visualize the adrenal glands and identify any tumors.
  • Magnetic Resonance Imaging (MRI) Scan: Provides detailed anatomical images, particularly helpful in differentiating tumors from other adrenal masses.

Genetic Testing: Recommended in cases with a family history of pheochromocytoma or associated genetic syndromes.

How the tumor affects the adrenal glands
The adrenal glands make the hormones adrenaline and noradrenaline, which are released into the bloodstream when needed. These hormones control heart rate, blood pressure and metabolism (the chemical processes that keep your organs working).

A phaeochromocytoma can cause the adrenal glands to produce too much of these hormones, which often results in problems such as heart palpitations and high blood pressure.

Management of Pheochromocytoma

Aims of management

The primary goals of managing pheochromocytoma are;

  • to control symptoms
  • stabilize blood pressure
  • ultimately remove the tumor.

1. Pre-operative Management (Medical Management)

Alpha-Adrenergic Blockers: These are the cornerstone of pre-operative management.

  • Mechanism: Alpha-blockers (e.g., phenoxybenzamine, doxazosin, prazosin) block the effects of norepinephrine on blood vessels, preventing vasoconstriction and reducing blood pressure.
  • Duration: Typically administered for 1-3 weeks before surgery to allow for adequate blood pressure control and expansion of blood volume.
  • Goal: To achieve adequate blood pressure control (target usually <130/80 mmHg) and minimize the risk of hypertensive crisis during surgery.

Beta-Adrenergic Blockers:

  • Use: Beta-blockers (e.g., propranolol, metoprolol) are only initiated after adequate alpha-blockade has been established.
  • Mechanism: Beta-blockers help control tachycardia (rapid heart rate) and arrhythmias caused by excess catecholamines.
  • Caution: Starting beta-blockers before alpha-blockers can lead to unopposed alpha-adrenergic stimulation, resulting in a dangerous hypertensive crisis.

Calcium Channel Blockers:

  • Use: May be used as adjunctive therapy or in patients who cannot tolerate alpha-blockers.
  • Mechanism: They help relax blood vessels and lower blood pressure.

Metyrosine:

  • Use: An alternative or adjunct to alpha and beta blockers.
  • Mechanism: Inhibits tyrosine hydroxylase, an enzyme involved in catecholamine synthesis.
  • Benefit: Can help reduce catecholamine levels and improve blood pressure control.

High-Sodium Diet and Fluid Intake:

  • Rationale: Pheochromocytomas can cause chronic vasoconstriction and reduced blood volume.
  • Goal: To expand blood volume and prevent hypotension after tumor removal.

Patient Education:

  • Importance: Patients need to understand the importance of medication adherence and monitoring blood pressure regularly.
  • Symptom Management: Educate patients on how to recognize and manage symptoms of catecholamine excess.

2. Surgical Management

Surgical Resection: The definitive treatment for pheochromocytoma.

Laparoscopic Adrenalectomy (“Keyhole” Surgery):

  • Approach: Preferred approach for most pheochromocytomas.
  • Advantages: Smaller incisions, less pain, shorter hospital stay, faster recovery.

Open Adrenalectomy:

  • Indications: Larger tumors, suspicion of malignancy, or when laparoscopic surgery is not feasible.
  • Approach: Requires a larger incision in the abdomen or flank.

Bilateral Adrenalectomy:

  • Indication: For bilateral pheochromocytomas (tumors in both adrenal glands).
  • Considerations: Requires lifelong hormone replacement therapy (glucocorticoids and mineralocorticoids).

Intraoperative Management:

  • Anesthesia: Requires careful monitoring and management by an experienced anesthesiologist.
  • Medications: Anesthesiologists use medications to manage blood pressure fluctuations during surgery.
  • Post-Resection Hypotension: Be prepared for hypotension after tumor removal due to sudden drop in catecholamine levels. Volume expansion and vasopressors may be required.

3. Management of Malignant Pheochromocytoma

Surgery: Resection of primary tumor and any metastases, if feasible.

Radiation Therapy: May be used to control local tumor growth or palliate symptoms.

Chemotherapy:

  • Regimens: Often involves a combination of cyclophosphamide, vincristine, and dacarbazine (CVD).
  • Efficacy: Response rates are variable.

Targeted Therapy:

  • Tyrosine Kinase Inhibitors (TKIs): (e.g., sunitinib) may be used in some cases.

Peptide Receptor Radionuclide Therapy (PRRT):

  • Mechanism: Uses radiolabeled somatostatin analogs to target tumor cells.

Radiofrequency Ablation (RFA) or Cryoablation:

  • Use: To treat liver or bone metastases.

4. Nursing Care

Pre-operative Care:

  • Monitoring: Frequent monitoring of vital signs (blood pressure, heart rate).
  • Medication Administration: Ensure accurate and timely administration of alpha and beta blockers.
  • Patient Education: Provide clear instructions about medications and potential side effects.

Post-operative Care:

  • Monitoring: Continuous monitoring of vital signs.
  • Fluid Management: Careful management of fluid balance to prevent hypotension or fluid overload.
  • Pain Management: Administer pain medication as prescribed.
  • Wound Care: Monitor incision site for signs of infection.
  • Hormone Replacement: If bilateral adrenalectomy was performed, initiate hormone replacement therapy and educate the patient on how to take the medications.

Long-Term Follow-Up:

  • Monitoring: Regular monitoring of blood pressure, catecholamine levels, and imaging studies to detect recurrence.
  • Genetic Counseling: Offer genetic counseling and testing, especially for patients with a family history of pheochromocytoma or associated genetic syndromes.

Nursing Care Plan: Pheochromocytoma

Assessment

Nursing Diagnosis

Goals/Expected Outcomes

Interventions

Rationale

Evaluation

Patient presents with hypertension, palpitations, headaches, excessive sweating, and anxiety. Laboratory results show elevated catecholamines.

Risk for Hypertensive Crisis related to excessive catecholamine secretion as evidenced by severe hypertension, palpitations, and headaches.

– Patient’s blood pressure will be maintained within normal limits. 


– Patient will report reduced episodes of palpitations and headaches. 


– Patient will avoid triggers that exacerbate symptoms.

1. Monitor blood pressure and heart rate frequently. 




2. Administer prescribed antihypertensive medications (alpha-blockers and beta-blockers). 

3. Educate patient on avoiding triggers like stress, caffeine, and strenuous activity. 

4. Prepare patient for surgical removal of the tumor (adrenalectomy) if indicated. 

5. Monitor for signs of hypertensive crisis (severe headache, visual disturbances, seizures).

1. Early detection of hypertensive episodes helps prevent complications. 

2. Controls blood pressure and prevents complications. 

3. Reduces catecholamine surges and symptom exacerbation. 

4. Definitive treatment to remove the source of excessive catecholamine secretion. 

5. Prevents life-threatening complications like stroke or myocardial infarction.

– Patient maintains stable blood pressure. 


– Patient reports reduced palpitations and headaches.


 – Patient adheres to lifestyle modifications.

Patient reports episodes of anxiety, excessive sweating, and restlessness. Patient appears nervous and agitated.

Anxiety related to catecholamine excess as evidenced by restlessness, tachycardia, and diaphoresis.

– Patient will verbalize reduced anxiety and use coping strategies. 


– Patient’s vital signs will remain stable.


 – Patient will participate in relaxation techniques.

1. Assess level of anxiety and provide a calm environment. 

2. Teach relaxation techniques (deep breathing, guided imagery). 



3. Administer prescribed anxiolytics if indicated. 

4. Reassure the patient and provide psychological support. 

5. Educate the patient on the physiological cause of symptoms.

1. Minimizes stress, which can trigger catecholamine release. 

2. Helps the patient manage anxiety episodes. 

3. Controls severe anxiety and autonomic symptoms. 

4. Reduces fear and emotional distress. 

5. Enhances understanding and reduces uncertainty.

– Patient verbalizes reduced anxiety. 


– Patient demonstrates relaxation techniques.


 – Vital signs remain within normal range.

Patient reports headaches, dizziness, and episodes of fainting.

Risk for Decreased Cardiac Output related to excessive catecholamine secretion as evidenced by tachycardia, hypertension, and palpitations.

– Patient will maintain stable cardiac function with normal heart rate and blood pressure.


 – Patient will remain free from syncope and dizziness.


 – Patient will adhere to prescribed medications and treatments.

1. Monitor ECG for arrhythmias and signs of myocardial strain. 

2. Assess for signs of heart failure (dyspnea, edema, chest pain). 

3. Administer beta-blockers or calcium channel blockers as prescribed. 

4. Encourage adequate hydration and sodium intake (if not contraindicated). 

5. Educate the patient about the importance of adherence to treatment.

1. Detects potential cardiac complications early. 

2. Prevents worsening of cardiac function. 

3. Helps regulate heart rate and blood pressure. 

4. Prevents dehydration-related hypotension. 

5. Ensures effective symptom management.

– Patient remains hemodynamically stable. 


– No episodes of dizziness or syncope.


 – Patient follows medication regimen.

Patient is scheduled for surgical tumor removal (adrenalectomy). Patient expresses fear and uncertainty about the procedure.

Deficient Knowledge related to unfamiliarity with pheochromocytoma and its management as evidenced by patient’s questions and concerns.

– Patient will verbalize understanding of the disease and treatment plan. 


– Patient will express reduced fear and anxiety about surgery.


 – Patient will adhere to preoperative and postoperative care instructions.

1. Explain pheochromocytoma, its effects, and treatment options. 

2. Educate patient on preoperative preparation, including medication use (e.g., alpha-blockers). 

3. Inform the patient about potential postoperative complications. 

4. Provide written educational materials for reinforcement. 

5. Encourage patient to ask questions and express concerns.

1. Increases patient understanding and reduces uncertainty. 

2. Ensures safe surgery by preventing hypertensive crisis. 

3. Helps the patient anticipate and manage postoperative recovery. 

4. Supports learning and recall of important information. 

5. Promotes active patient participation in care.

– Patient demonstrates understanding of condition and treatment.


 – Patient verbalizes reduced fear about surgery.


 – Patient follows preoperative and postoperative instructions.

Patient is unable to engage in normal activities due to fatigue, dizziness, and palpitations.

Activity Intolerance related to catecholamine-induced cardiovascular instability as evidenced by fatigue, dizziness, and exertional dyspnea.

– Patient will gradually resume activities without excessive fatigue.


 – Patient will report improved tolerance to physical exertion.


 – Patient will engage in energy-conserving techniques.

1. Assess activity tolerance and monitor for symptoms of intolerance. 

2. Encourage rest periods between activities. 


3. Teach energy conservation strategies. 



4. Gradually reintroduce physical activity as tolerated. 

5. Monitor blood pressure and heart rate during activity.

1. Prevents overexertion and worsening of symptoms. 

2. Conserves energy and prevents fatigue. 

3. Helps the patient manage limited energy levels. 

4. Improves endurance and quality of life. 

5. Ensures hemodynamic stability during exertion.

– Patient engages in activities with minimal fatigue. 


– Patient reports improved energy levels. 


– Vital signs remain stable during exertion.

Pheochromocytoma Read More »

Addison’s disease (Adrenal insufficiency)

Addison’s disease (Adrenal insufficiency)

Addison’s Disease (Adrenal Insufficiency) 

Addison’s disease, also known as primary adrenal insufficiency, is a rare disorder characterized by the insufficient production of hormones by the adrenal glands.

Addison’s disease is a clinical condition characterized by adrenocorticotrophic hormone hyposecretion due to primary disease of the adrenal glands or secondary to pituitary gland disorder.

The adrenal glands, located above the kidneys, produce hormones such as cortisol and aldosterone that are essential for maintaining normal bodily functions.

It’s mostly idiopathic or auto immune but can occur in tuberculosis infection of the gland or  obstruction by the adrenal tumor, metastasis / hemorrhage

Hormones Produced by the Adrenal Cortex

Hormone

Examples of the Hormone

Effects of the Hormone

Glucocorticoids

Cortisol, Cortisone, Hydrocortisone

– Protein Breakdown: Enhances the breakdown of proteins, especially in muscle cells, to release amino acids.

– Glucose Formation: Promotes gluconeogenesis, converting non-carbohydrate sources into glucose, raising blood sugar levels.

– Lipolysis: Stimulates the breakdown of stored fats into fatty acids and glycerol.

– Resistance to Stress: Increases blood pressure and blood glucose, providing the body with energy to handle stress.

– Anti-inflammatory Effects: Inhibits white blood cells that participate in inflammatory responses, reducing inflammation and allergic reactions.

– Depression of Immune Responses: Lowers the activity of the immune system, which can decrease the body’s ability to fight infections.

Mineralocorticoids

Aldosterone

– Electrolyte Balance: Regulates sodium (Na⁺) and potassium (K⁺) ions, maintaining blood pressure and fluid balance.

– Blood Pressure Regulation: Adjusts blood pressure and blood volume by increasing sodium retention and water reabsorption in the kidneys.

– Acid-Base Balance: Promotes the excretion of hydrogen ions (H⁺) in the urine, preventing acidosis and helping to maintain blood pH.

Androgens

Dehydroepiandrosterone (DHEA), Androstenedione

– Secondary Sexual Characteristics: Influence the development of male secondary sexual characteristics, such as facial hair and deepening of the voice.

– Sex Drive: Contribute to libido in both males and females.

– Precursor for Estrogen: In postmenopausal women, androgens serve as precursors for estrogen synthesis.

Hormones Produced by the Adrenal Medulla

Hormone

Cells that Produce It

Action of the Hormone

Adrenaline (Epinephrine)

Chromaffin Cells

– Fight or Flight Response: Increases heart rate, blood pressure, and blood glucose levels; dilates airways to prepare the body for stress.

– Energy Mobilization: Stimulates the breakdown of glycogen to glucose in the liver, providing quick energy.

– Increased Alertness: Enhances alertness and readiness by stimulating the central nervous system.

Noradrenaline (Norepinephrine)

Chromaffin Cells

– Fight or Flight Response: Similar to adrenaline, it constricts blood vessels to increase blood pressure and redirects blood flow to vital organs.

– Vasoconstriction: Causes blood vessels to constrict, which increases peripheral resistance and helps maintain blood pressure during stress.

Pathophysiology of Adrenal Insufficiency

Adrenal glands are incapable of producing sufficient cortisol and other steroids . It is distinguished from acute primary adrenocortical insufficiency caused by Waterhouse-Friderichsen syndrome.

Mineralocorticoid deficiency: Because mineralocorticoids stimulate sodium reabsorption and potassium excretion, deficiency results in increased excretion of sodium and decreased excretion of potassium, chiefly in urine but also in sweat, saliva, and the gastrointestinal tract. A low serum concentration of sodium (hyponatremia) and a high concentration of potassium (hyperkalemia) result.

Urinary salt and water loss cause severe dehydration, plasma hypertonicity, acidosis, decreased circulatory volume, hypotension, and, eventually, circulatory collapse. However, when adrenal insufficiency is caused by inadequate adrenocorticotropic hormone (ACTH) production (secondary adrenal insufficiency), electrolyte levels are often normal or only mildly deranged, and the circulatory problems are less severe.

Glucocorticoid deficiency: Glucocorticoid deficiency contributes to hypotension and causes severe insulin sensitivity and disturbances in carbohydrate, fat, and protein metabolism. In the absence of cortisol, insufficient carbohydrate is formed from protein; hypoglycemia and decreased liver glycogen result. Weakness follows, due in part to deficient neuromuscular function. Resistance to infection, trauma, and other stress is decreased. Myocardial weakness and dehydration reduce cardiac output, and circulatory failure can occur.

Decreased blood cortisol results in increased pituitary ACTH production and increased blood beta-lipotropin, which has melanocyte-stimulating activity and, together with ACTH, causes the hyperpigmentation of skin and mucous membranes characteristic of Addison disease. Thus, adrenal insufficiency secondary to pituitary failure does not cause hyperpigmentation.

Addison's

Causes of Addison’s Disease(Can be predisposing Factors too)

  1. Autoimmune Reaction: Addison’s Disease can occur when the body’s immune system mistakenly attacks and damages the adrenal glands. This is known as an autoimmune reaction. In this case, the immune system views the adrenal glands as foreign entities and targets them for destruction, leading to a deficiency in adrenal hormones.
  2. Idiopathic Atrophy of the Adrenal Glands: In some cases, the adrenal glands may undergo atrophy, which means they shrink and lose their function without a clear identifiable cause. This condition is referred to as idiopathic adrenal atrophy.
  3. Surgical Removal of Both Adrenal Glands: Addison’s Disease can result from the surgical removal of both adrenal glands. This usually occurs as a last resort when treating conditions such as Cushing’s syndrome or adrenal tumors. After removal, the individual will need hormone replacement therapy.
  4. Adrenal Carcinoma: Adrenal carcinoma is a rare type of cancer that originates in the adrenal glands. In some instances, the cancerous growth can disrupt the normal functioning of the adrenal glands, leading to adrenal insufficiency and Addison’s Disease.
  5. Infections such as TB: Certain infections, particularly tuberculosis (TB), can infiltrate and damage the adrenal glands. TB-induced damage to the adrenal glands can impair their ability to produce hormones, causing Addison’s Disease.
  6. Abnormal/Malfunction of the Pituitary Gland: The pituitary gland plays a crucial role in regulating adrenal function by secreting adrenocorticotropic hormone (ACTH). If the pituitary gland malfunctions and doesn’t produce an adequate amount of ACTH, the adrenal glands won’t receive the necessary signals to produce hormones, leading to Addison’s Disease.
  7. Prolonged Use of Steroid Medication: Long-term use of corticosteroid medications, which are often prescribed for conditions like autoimmune diseases or inflammation, can suppress the production of ACTH by the pituitary gland. This can lead to adrenal gland atrophy and result in Addison’s Disease.

Additional causes  include:

  • Genetic Factors: While most cases of Addison’s Disease are not inherited, there is a rare genetic form known as familial glucocorticoid deficiency (FGD). In FGD, specific genetic mutations can lead to the inadequate production of adrenal hormones.
  • Hemorrhage into the Adrenal Glands: Severe bleeding into the adrenal glands, often due to injury or other medical conditions, can damage the glands and impair their hormone production.
  • Amyloidosis: Amyloidosis is a rare condition in which abnormal proteins (amyloids) build up in various organs, including the adrenal glands. This accumulation can disrupt adrenal function and cause Addison’s Disease.
Clinical Presentation of Addison's Disease

Clinical Presentation of Addison’s Disease:

Due to Cortisol Deficiency: Addison’s Disease primarily results in the deficiency of cortisol, which is a crucial hormone for various bodily functions.

Common symptoms due to cortisol deficiency include:

  • Weakness: Individuals with Addison’s Disease often experience significant weakness, making even simple tasks challenging.
  • Weight Loss: Unexplained weight loss can occur due to a disruption in metabolism.
  • Fatigue: Profound fatigue and tiredness are typical, even after a full night’s sleep.
  • Nausea and Vomiting: Persistent nausea and vomiting may be present.
  • Diarrhea: Chronic diarrhea can develop as a result of gastrointestinal disturbances.

Due to Increased ACTH Production (If the Cause Is in the Adrenal Gland): When Addison’s Disease is caused by issues within the adrenal glands, it can lead to increased production of adrenocorticotropic hormone (ACTH).

Symptoms related to excess ACTH include:

  • Hyperpigmentation of Skin and Mucous Membranes: A distinctive symptom is the darkening of the skin and mucous membranes, which may appear as tan or bronze patches. This is often referred to as hyperpigmentation.

Due to Mineralocorticoid Deficiency: Addison’s Disease can also lead to the deficiency of mineralocorticoids, particularly aldosterone, which plays a crucial role in regulating electrolyte balance.

Symptoms associated with mineralocorticoid deficiency include:

  • Very Low Blood Pressure (Hypotension): The absence of aldosterone can result in extremely low blood pressure, leading to dizziness and fainting.
  • Serum Potassium High, but Sodium and Chloride Are Low: Electrolyte imbalances can manifest as high levels of potassium and low levels of sodium and chloride.

Due to Androgen Deficiency: In some cases, Addison’s Disease may also cause androgen deficiency, which can lead to specific symptoms:

  • Sparse Hair in Females: Women with Addison’s Disease may experience hair thinning or loss.
  • General Weakness: Overexertion, exposure to cold, or acute infections can exacerbate the overall weakness and fatigue experienced by individuals with Addison’s Disease.

Other symptoms: Dizziness, headache, and menstrual irregularities in women may also occur.

In severe cases, adrenal crisis can occur, which is a life-threatening condition characterized by 

  • extremely low blood pressure, electrolyte imbalances, and shock.

CLASSIC TRIAD/CARDINAL SIGNS

Hyperpigmentation: A darkening of the skin, MOSTLY in areas exposed to the sun and areas of friction or pressure.

The hyperpigmentation is a result of increased production of melanin due to elevated levels of adrenocorticotropic hormone (ACTH).

Weakness and Fatigue: Individuals with Addison’s disease often experience generalized weakness and fatigue.

This is attributed to the deficiency of glucocorticoids, such as cortisol, which play a crucial role in maintaining energy balance.

Low Blood Pressure (Hypotension): Addison’s disease can lead to decreased production of aldosterone, contributing to low blood volume and hypotension (low blood pressure).

Electrolyte imbalances, particularly low sodium levels, also play a role in hypotension.

DIAGNOSTIC EVALUATION

History collection

  • History of recent infection, steroid use, or adrenal or pituitary surgery.
  • History of poor tolerance for stress, weakness, fatigue, and activity intolerance.
  • Anorexia, nausea, vomiting, or diarrhea as a result of altered metabolism.
  • Dizziness due to orthostatic hypotension.
  • History of craving for salt or intolerance to cold.
  • Presence of altered menses in females and impotence in males.

Physical examination

  • Signs of dehydration such as tachycardia, altered level of consciousness, dry skin with poor turgor, dry mucous membranes, weight loss, and weak peripheral pulses.
  • Postural hypotension
  • Inspect the skin for pigmentation changes
  • Inspect the patient’s gums and oral mucous membranes to see if they are bluish-black.
  • Temperature
  • Any loss of axillary and pubic hair that could be caused by decreased androgen levels.

Investigations

1. ACTH stimulation test

  • Short test: compares blood cortisol levels before and after 250 mcg of tetracosactide (IM/IV) is given.
  • Increased ACTH level: Primary insufficiency
  • Decreased ACTH level: Secondary insufficiency

2. Other investigations

  • Complete blood count (CBC): Anaemia
  • Blood urea nitrogen (BUN): Increased
  • Electrocardiography (ECG): Shows low voltage and peaked T waves caused by hyperkalaemia
  • Computed Tomography (CT) scan and Magnetic Resonance Imaging (MRI): To assess the adrenal glands
  • Urine cortisol and aldosterone: Decreased
  • Hypoglycaemia, hyponatremia, hyperkalaemia, leukocytosis.

Complications of Addison’s Disease:

Renal Failure:

  • One of the potential complications of Addison’s Disease is renal failure, which refers to the loss of kidney function.
  • Addison’s Disease can disrupt the balance of electrolytes in the body, particularly causing increased levels of potassium. This imbalance can have a detrimental effect on the kidneys.
  • High levels of potassium can lead to abnormal heart rhythms (arrhythmias) and, in severe cases, impair kidney function.

Adrenal Hemorrhage:

  • Adrenal hemorrhage, though rare, is another complication that can occur in individuals with Addison’s Disease.
  • It involves bleeding into the adrenal glands, typically due to an adrenal crisis or severe stress. This can lead to sudden and severe abdominal or back pain.
  • Adrenal hemorrhage requires immediate medical attention, as it can be life-threatening.

Addisonian Crisis:

  • An Addisonian crisis, also known as an adrenal crisis, is a severe and potentially life-threatening complication of Addison’s Disease.
  • It occurs when the adrenal glands fail to produce enough cortisol to meet the body’s needs, often triggered by stress, illness, trauma, or abrupt cessation of corticosteroid medications.
  • Symptoms of an Addisonian crisis can include extreme weakness, confusion, low blood pressure, rapid heart rate, and even loss of consciousness.
  • Prompt emergency medical treatment is essential to stabilize the patient, typically through intravenous administration of cortisol and fluids.

Depression:

  • Chronic illnesses like Addison’s Disease can lead to emotional and psychological challenges, including depression.
  • Coping with the demands of managing a chronic condition, along with the physical symptoms and potential complications, can take a toll on a person’s mental health.
  • It’s essential for individuals with Addison’s Disease to receive comprehensive care that includes addressing emotional well-being and providing support for mental health issues such as depression.

Management of Addison’s Disease

The management of Addison’s disease involves lifelong hormone replacement therapy to compensate for the deficiency of cortisol and aldosterone. Treatment aims to:

Replace missing hormones:

  • Glucocorticoids: Hydrocortisone is the most commonly used glucocorticoid, administered in divided doses throughout the day to mimic the body’s natural cortisol production. (hydrocortisone-15 mg on waking and 5 mg at 6p.m.)
  • Mineralocorticoids: Fludrocortisone is the primary mineralocorticoid used to replace aldosterone. (fludrocortisone 0.05 to 0.1mg daily).
  • If the adrenal gland does not regain function, the patient needs lifelong replacement of corticosteroids and mineralocorticoids to prevent recurrence of adrenal insufficiency.

Manage complications:

  • Addisonian crisis: A life-threatening emergency caused by severe adrenal insufficiency. It requires immediate medical attention with intravenous fluids, electrolyte replacement, and high doses of hydrocortisone.

Treatment of patient with Addisonian crisis

  • Administration of fluid, glucose, and electrolytes, especially sodium.
  • Replacement of missing steroid hormones; and vasopressors(Vasopressors are drugs used to raise blood pressure in people whose blood pressure is very low.)
  • Large volumes of 0.9% saline solution and 5% dextrose are administered to reverse hypotension and electrolyte imbalances until blood pressure returns to normal.

Electrolyte imbalances: Regular monitoring of electrolytes (sodium, potassium) and prompt correction of imbalances are crucial.

Osteoporosis: Glucocorticoid therapy can increase the risk of osteoporosis. Calcium and vitamin D supplementation, along with weight-bearing exercises, are recommended.

Patient education:

  • Self-management: Patients need to learn about their condition, medication regimen, and how to recognize and manage symptoms.
  • Emergency preparedness: Patients should carry an emergency kit containing injectable hydrocortisone and a medical identification card.
  • Stress management: Patients should avoid excessive stress and learn techniques to manage stress effectively.
  • Dietary modifications: A balanced diet with adequate salt intake is essential.
  • Supplement dietary intake with salt during GI losses of fluids through vomiting and diarrhoea.
  • Regular follow-up: Regular visits with a healthcare provider are necessary to monitor the patient’s condition and adjust medication doses as needed.

Nursing Interventions. 

  1.  Hormone Replacement Therapy: Collaborate with the healthcare team to ensure the patient receives appropriate hormone replacement therapy, with glucocorticoids (such as hydrocortisone) and mineralocorticoids (such as fludrocortisone). Administer medications as prescribed and monitor for the desired therapeutic response. 
  2.  Medication Education: Provide education to the patient and their family regarding the importance of adhering to the prescribed medication regimen. Explain the purpose, dosage, timing, and potential side effects of hormone replacement medications.
  3.  Stress Management: Educate the patient about the need for increased medication during times of physical or emotional stress, such as illness, injury, or surgery. Instruct them to carry an emergency card or wear a medical alert bracelet to inform others about their condition. 
  4. Fluid and Electrolyte Balance: Monitor the patient’s fluid intake and output and assess for signs of dehydration or electrolyte imbalances. Encourage the patient to maintain adequate hydration and offer oral rehydration solutions as needed. 
  5. Blood Pressure Monitoring: Regularly measure the patient’s blood pressure to assess for hypotension. Collaborate with the healthcare team to adjust medication dosages if necessary to maintain appropriate blood pressure levels. 
  6. Dietary Education: Provide dietary education to the patient, emphasizing the importance of a well-balanced diet with adequate sodium intake. Encourage the patient to include foods rich in sodium in their diet or consult with a dietitian for personalized guidance.
  7.  Emotional Support: Provide emotional support and encourage open communication with the patient. Offer a safe space for them to express any concerns, fears, or emotional challenges related to their condition. 
  8. Education on Recognizing and Managing Emergencies: Educate the patient and their family about the signs and symptoms of adrenal crisis, a life-threatening condition that can occur in Addison’s disease. Instruct them to seek immediate medical help if symptoms such as severe weakness, dizziness, abdominal pain, or altered consciousness occur.  Increase dosage in times of stress.
  9. Collaboration and Referrals: Collaborate with the healthcare team to ensure comprehensive care for the patient. This may involve referrals to specialists such as endocrinologists or social workers who can provide additional support and resources. 

Nursing Concerns in Addison’s Disease:

Hypotension and Fluid Balance:

  • Concern for the patient’s risk of hypotension and dehydration.
  • Monitoring blood pressure and fluid status, implementing interventions to address imbalances.

Electrolyte Imbalances:

  • Concern for potential electrolyte imbalances, such as hyponatremia and hyperkalemia.
  • Regular monitoring of electrolyte levels and interventions to maintain balance.

Adrenal Crisis Risk:

  • Concern for the risk of adrenal crisis during stress or illness.
  • Patient education on stress dosing and vigilant monitoring during times of increased stress.

Medication Adherence:

  • Concern for adherence to medication regimens.
  • Assessing the patient’s understanding of the importance of medication compliance.

Skin Integrity:

  • Concern for skin changes and hyperpigmentation.
  • Regular skin assessments and education on skin care to prevent breakdown.

Medical Management

  • Restore blood circulation IV fluids NS and Dextrose.
  • Small dose of fludrocortisones 0.05 – 0.1mg/day is given to maintain BP and electrolytes
  • Hormone replacement with cortisone daily in divided doses i.e prednisolone 20mg in the  morning and 10mg in the evening
  • Vasopressor amines may be required if hypertension persists.
  • Antibiotic therapy if infection has precipitated the adrenal crisis
  • Lifelong replacement of corticosteroids and mineralocorticoids.
  • ORS for salt replacement.
  • May need additional salt intake
  • Treat underlying cause ie TB

Nursing Care

  • Monitor for BP,P, as patient moves from lying, sitting, and standing position to asses for inadequate fluid volume.
  • Assess skin color and turgor
  • Assess history of weight changes, muscle weakness, and fatigue.
  • Ask patient and family about onset of illness or increased stress that may have precipitated the crisis

Nursing diagnosis

  • Electrolyte imbalance related to low sodium level as evidenced by craving for salt, vomiting and diarrhea.
  • Ineffective tissue perfusion related to hyperpigmentation of skin as evidenced by skin tanning.
  • Risk for fluid volume deficit related to vomiting and diarrhea.

.

Nursing care plan for Addison’s disease:

Assessment

Nursing Diagnosis

Goals/Expected Outcomes

Interventions

Rationale

Evaluation

1. Patient reports fatigue, muscle weakness, and dizziness.

Activity Intolerance related to fatigue and muscle weakness as evidenced by the patient reporting the inability to perform daily activities without exhaustion.

The patient will demonstrate increased energy levels and participate in daily activities with minimal fatigue.

– Encourage rest periods between activities to conserve energy.

– Assist with activities of daily living (ADLs) as needed.

– Educate the patient on the importance of balancing activity and rest.

Rest periods prevent exhaustion and allow for energy conservation.

Assistance with ADLs reduces the physical strain on the patient.

Education promotes effective energy management.

The patient reports increased energy and is able to participate in daily activities with minimal fatigue.

2. Patient presents with hypotension, darkened skin, and weight loss.

Deficient Fluid Volume related to adrenal insufficiency as evidenced by hypotension, weight loss, and decreased skin turgor.

The patient will maintain adequate fluid volume as evidenced by stable blood pressure and normal skin turgor.

– Monitor vital signs, especially blood pressure, regularly.

– Administer prescribed corticosteroid therapy (e.g., hydrocortisone).

– Encourage increased oral fluid intake, and administer IV fluids as needed.

– Educate the patient on recognizing signs of dehydration and the importance of fluid intake.

Monitoring vital signs detects changes in fluid status.

Corticosteroid therapy helps manage adrenal insufficiency.

Increased fluid intake and IV fluids help maintain fluid balance.

Education empowers the patient to prevent dehydration.

The patient maintains stable blood pressure and demonstrates normal skin turgor.

3. Patient expresses concern about skin changes and weight loss.

Disturbed Body Image related to hyperpigmentation and weight loss as evidenced by the patient verbalizing distress about appearance.

The patient will verbalize acceptance of their appearance and demonstrate positive body image behaviors.

– Provide emotional support and counseling to address concerns about appearance.

– Encourage participation in self-care and grooming activities.

– Refer to a support group or counselor specializing in chronic illness.

Emotional support helps the patient cope with changes in appearance.

Self-care activities can enhance self-esteem.

Support groups provide a network for shared experiences and coping strategies.

The patient reports acceptance of their appearance and demonstrates positive body image behaviors.

4. Patient reports nausea, vomiting, and decreased appetite.

Imbalanced Nutrition: Less than Body Requirements related to nausea and vomiting as evidenced by weight loss and decreased appetite.

The patient will maintain adequate nutritional intake and demonstrate stable weight.

– Monitor daily weight and nutritional intake.

– Offer small, frequent meals with high-calorie, nutrient-dense foods.

– Administer antiemetics as prescribed to control nausea.

– Collaborate with a dietitian to develop a nutrition plan that meets the patient’s needs.

Monitoring weight and intake helps assess nutritional status.

Small, frequent meals are easier to tolerate and help maintain calorie intake.

Antiemetics reduce nausea and improve appetite.

A dietitian can tailor a nutrition plan to the patient’s needs.

The patient maintains stable weight and reports improved appetite.

5. Patient reports feelings of anxiety about managing the disease and its symptoms.

Anxiety related to chronic illness and potential complications as evidenced by patient verbalizing concerns about managing Addison’s disease.

The patient will verbalize reduced anxiety and demonstrate effective coping strategies.

– Assess the patient’s understanding of Addison’s disease and its management.

– Provide education on the disease, including symptom management and when to seek medical help.

– Teach stress management techniques, such as deep breathing exercises and relaxation techniques.

– Refer the patient to a counselor or support group if needed.

Understanding the disease reduces fear and anxiety.

Education empowers the patient to manage their condition effectively.

Stress management techniques help reduce anxiety levels.

Counseling or support groups provide additional emotional support.

The patient reports reduced anxiety and effectively manages the disease with appropriate coping strategies.

6. Patient presents with a blood glucose level of 60 mg/dL, sweating, and confusion.

Risk for Hypoglycemia related to impaired gluconeogenesis and decreased cortisol levels.

The patient will maintain blood glucose levels within the normal range.

– Monitor blood glucose levels regularly.

– Educate the patient on recognizing early signs of hypoglycemia, such as sweating, shaking, and confusion.

– Administer glucose or dextrose as prescribed in case of hypoglycemia.

– Encourage the patient to carry fast-acting carbohydrates (e.g., glucose tablets) at all times.

Regular monitoring detects hypoglycemia early.

Early recognition allows for prompt intervention.

Glucose administration rapidly corrects hypoglycemia.

Carrying fast-acting carbohydrates ensures the patient can quickly address hypoglycemia.

 

Addison’s disease (Adrenal insufficiency) Read More »

dwarfism

Dwarfism (Panhypopituitarism)

Dwarfism (Panhypopituitarism) 

Dwarfism is a medical condition characterized by short stature. 

It is defined as an adult height of 4 feet 10 inches (147 centimeters) or shorter. There are different types of dwarfism, which can be caused by various underlying factors.

It is a condition characterized by the underproduction or deficiency of several hormones produced by the pituitary gland. The primary hormones affected in panhypopituitarism include: 

  1. Growth hormone (GH): GH plays a key role in stimulating growth and development in children. Its deficiency can result in impaired growth and short stature. 
  2. Thyroid-stimulating hormone (TSH): TSH regulates the function of the thyroid gland, which affects metabolism, energy levels, and growth. Deficiency of TSH can lead to thyroid hormone deficiency. 
  3. Adrenocorticotropic hormone (ACTH): ACTH stimulates the production of cortisol by the adrenal glands. Its deficiency can result in adrenal insufficiency. 
  4. Gonadotropins (Luteinizing hormone [LH] and Follicle-stimulating hormone [FSH]): These hormones regulate the function of the gonads (testes in males, ovaries in females) and play a crucial role in reproductive function. Deficiency of gonadotropins can lead to infertility and sexual dysfunction. 
  5. Prolactin: Prolactin is involved in milk production in females. Its deficiency may result in decreased lactation in breastfeeding women.

Types of Dwarfism

There are two main types of dwarfism — disproportionate and proportionate.

Disproportionate dwarfism: Disproportionate dwarfism is characterized by an average-size torso and shorter arms and legs or a shortened trunk with longer limbs. The most common types of dwarfism, known as skeletal dysplasia’s, are genetic. Skeletal dysplasia’s are conditions of abnormal bone growth that cause disproportionate dwarfism.

Skeletal dysplasia’s include:

1.  Achondroplasia: The most common cause of dwarfism which causes disproportionately short stature. This is the most common form of dwarfism, occurs in about one out of 26,000 to 40,000 babies and is evident at birth. People with achondroplasia have a relatively long trunk and shortened upper parts of their arms and legs.

    • This disorder usually results in the following:
    • An average-size trunk
    • Short arms and legs, with particularly short upper arms and upper legs
    • Short fingers, often with a wide separation between the middle and ring fingers
    • Limited mobility at the elbows
    • An adult height around 4 feet (122 cm)
    • a large head with a prominent forehead and a flattened bridge of the nose
    • protruding jaw
    • crowded and misaligned teeth
    • forward curvature of the lower spine
    • Progressive development of bowed legs

2.  Spondyloepiphyseal dysplasia Congenita (SEDC): Another rare cause of disproportionate dwarfism that affects approximately one in 95,000 babies. It refers to a group of conditions characterized by a shortened trunk, which may not become apparent until a child is between ages 5 and 10.

  • A very short trunk
  • A short neck
  • Shortened arms and legs
  • Average-size hands and feet
  • Slightly flattened cheekbones
  • Hip deformities that result in thighbones turning inward
  • Instability of the neck bones.
  • Progressive hunching curvature of the upper spine.
  • Progressive development of swayed lower back
  • Vision and hearing problems.
  • Arthritis and problems with joint movement.
  • Adult height ranging from 3 feet (91 cm) to just over 4 feet (122 cm).
  • club feet (A foot that’s twisted or out of shape).
  • Opening in the roof of the mouth (cleft palate).
  • severe osteoarthritis in the hips
  • weak hands and feet.
  • barrel-chested appearance (Broad, rounded chest)

3.  Diastrophic dysplasia: A rare form of dwarfism, diastrophic dysplasia occurs in about one in 100,000 births. People who have it tend to have shortened forearms and calves (calf muscles-this is known as mesomelic shortening).

achondroplasis

Achondroplasia

SDC

Spondyoepipheseal

Diastrophic

Proportionate dwarfism: In Proportionate dwarfism, the body parts are in proportion but shortened. It usually results from medical conditions present at birth or appearing in early childhood that limit overall growth and development. So the head, trunk and limbs are all small, but they’re proportionate to each other. Because these disorders affect overall growth, many of them result in poor development of one or more body systems. Growth hormone deficiency is a relatively common cause of proportionate dwarfism. It occurs when the pituitary gland fails to produce an adequate supply of growth hormone, which is essential for normal childhood growth.

Signs include:

  • Height below the third percentile on standard pediatric growth charts
  • Growth rate slower than expected for age
  • Delayed or no sexual development during the teen years.

Causes of Dwarfism

  • Most dwarfism-related conditions are genetic disorders, but the causes of some disorders are unknown. Most occurrences of dwarfism result from a random genetic mutation in either the father’s sperm or the mother’s Ovum rather than from either parent’s complete genetic makeup.
  • Dwarfism can be caused by any of more than 200 conditions. Causes of proportionate dwarfism include metabolic and hormonal disorders such as growth hormone deficiency.
  • The most common types of dwarfism, known as skeletal dysplasias, are genetic. Skeletal dysplasias are conditions of abnormal bone growth that cause disproportionate dwarfism.

Other causes include;

  • Deficiency of growth hormone
  • Malnutrition
  • Inherited defect i.e. turners syndrome(Turner syndrome, a condition that affects only girls and women, results when a sex chromosome (the X chromosome) is missing or partially missing. A female inherits an X chromosome from each parent. A girl with Turner syndrome has only one fully functioning copy of the female sex chromosome rather than two)
  • Renal disorders
  • Congenital heart disease
  • Chronic infection in childhood

Diagnosis of Dwarfism

  • Some forms of dwarfism are evident at birth or during infancy and can be diagnosed through X-rays and a physical exam.
  • A diagnosis of achondroplasia, diastrophic dysplasia, or spondyloepiphyseal dysplasia can be confirmed through genetic testing. In some cases, prenatal testing is done if there is concern for specific conditions.
  • Sometimes dwarfism doesn’t become evident until later in a child’s life, when dwarfism signs lead parents to seek a diagnosis. Here are signs and symptoms to look for in children that indicate a potential for dwarfism:
    • Late development of certain motor skills, such as sitting up or walking.
    • Breathing problems
    • Curvature of the spine
    • bowed legs
    • Joint stiffness and arthritis
    • Lower back pain or numbness in the legs
    • Crowding of teeth.
  • Measurements. A regular part of a well-baby medical exam is the measurement of height, weight and head circumference. At each visit, they will be plotted on a chart to show the child’s current percentile ranking for each one. This is important for identifying abnormal growth, such as delayed growth or a disproportionately large head. If any trends in these charts are a concern, the health worker may make more-frequent measurements.
  • Appearance. A child’s appearance may also help to make a diagnosis. Many distinct facial and skeletal features are associated with each of several dwarfism disorders.
  • Imaging technology. Imaging studies, such as X-rays, may be ordered because certain abnormalities of the skull and skeleton can indicate which disorder a child may have. Various imaging devices may also reveal delayed maturation of bones, as is the case in growth hormone deficiency.
  • A magnetic resonance imaging (MRI) scan may reveal abnormalities of the pituitary gland or hypothalamus, both of which play a role in hormone function.
  • Genetic tests. Genetic tests are available for many of the known causal genes of dwarfism-related disorders, but these tests often aren’t necessary to make an accurate diagnosis. If the pediatrician believes the daughter may have Turner syndrome, then a special lab test may be done that assesses the X chromosomes extracted from blood cells.
  • Family history. The pediatrician may take a history of stature in siblings, parents, grandparents or other relatives to help determine whether the average range of height in the family includes short stature.
  • Hormone tests. Tests that assess levels of growth hormone or other hormones that are critical for childhood growth and development may be ordered.

Management of Dwarfism

Treatment for Underlying Cause: Focus on addressing the specific cause of dwarfism, if possible.

Growth Hormone Therapy: GH injections can be administered to stimulate growth in children and adolescents.

Physical Therapy:

  • Improve Mobility: Develop strategies to compensate for mobility limitations.
  • Strengthen Muscles: Improve overall strength and endurance.

Psychological Support:

  • Counseling: Address any emotional issues related to self-esteem, body image, and social integration.
  • Support Groups: Connect with others who have dwarfism to share experiences and build support networks.

Nursing Care:

Education and Support:

  • Provide comprehensive information about dwarfism, its causes, and treatment options.
  • Encourage open communication and emotional support for the individual and their family.

Medication Administration:

  • Administer GH injections accurately and monitor for side effects.
  • Educate patients and families about proper injection techniques and storage.

Physical Care:

  • Assess mobility, and provide assistive devices and adaptive techniques as needed.
  • Promote healthy weight management and encourage regular exercise.

Emotional Support:

  • Empathize with the challenges of living with dwarfism and provide emotional support.
  • Facilitate access to counseling and support groups for the individual and their family.

Advocacy:

  • Advocate for the individual’s needs and rights.
  • Connect them with resources and support services for people with dwarfism.

Nursing Concerns:

  1. Growth Hormone Therapy: Monitor for side effects of GH treatment, such as fluid retention, joint pain, and increased risk of diabetes.
  2. Mobility and Safety: Assess for potential falls and injuries related to mobility limitations. Provide modifications and adaptations to improve safety in the home and community.
  3. Psychological Well-being: Monitor for signs of depression, anxiety, and social isolation. Promote self-esteem and body image through counseling and support groups.
  4. Accessibility: Advocate for accessible environments and accommodations for individuals with dwarfism.
  5. Long-Term Management: Educate individuals and families about the lifelong implications of dwarfism and the need for ongoing care and support.

Surgical Management

  • Surgical procedures that may correct problems in people with disproportionate dwarfism include:
  • Correcting the direction in which bones are growing
  • Stabilizing and correcting the shape of the spine
  • Increasing the size of the opening in bones of the spine (vertebrae) to alleviate pressure on the spinal cord
  • Placing a shunt to remove excess fluid around the brain (hydrocephalus), if it occurs to drain excess fluid and relieve pressure on the brain.

Limb lengthening

  • Some people with dwarfism choose to undergo surgery called extended limb lengthening. This procedure is controversial for many people with dwarfism because, as with all surgeries, there are risks.
  • Because of the emotional and physical stress of multiple procedures, waiting until the person with dwarfism is old enough to participate in the decision to have the surgery is recommended.

Ongoing health care

  • Regular checkups and ongoing care by a doctor familiar with dwarfism can improve quality of life.
  • Because of the range of symptoms and complications, treatments are tailored to address problems as they occur, such as assessment and treatment for ear infections, spinal stenosis or sleep apnea.
  • Adults with dwarfism should continue to be monitored and treated for problems that occur throughout life.

  • In many cases, people with dwarfism have orthopaedic or medical complications. Treatment of those can include:

    • A tracheotomy to improve breathing through small airways.
    • Corrective surgeries for deformities such as cleft palate, club foot, or bowed legs
    • Surgery to remove tonsils or adenoids to improve breathing problems related to large tonsils, small facial structures, and/or a small chest.
    • Surgery to widen the spinal canal to relieve spinal cord compression.

Other treatments may include:

  • Physical therapy to strengthen muscles and increase joint range of motion.
  • Back braces to improve curvature of the spine
  • Placement of draining tubes in the middle ear to help prevent hearing loss due to repeated ear infections.
  • Orthodontic treatment to relieve crowding of teeth caused by a small jaw.
  • Nutritional guidance and exercise to help prevent obesity, which can aggravate skeletal problems.

Life style and home remedies 

  • Talk with the pediatrician or a specialist about home care. Issues particularly critical for children with disproportionate dwarfism include:
  • Car seats. Use an infant car seat with firm back and neck supports. Continue using a car seat in the rear-facing direction to the highest weight and height possible (and beyond the recommended age limit).
  • Infant carriers and play equipment. Avoid infant devices such as swings, umbrella strollers, carrying slings, jumper seats and backpack carriers that don’t support the neck or that curve the back into a C shape.
  • Adequate support. Support the child’s head and neck when he or she is seated.
  • Complications. Monitor the child for signs of complications, such as ear infection or sleep apnea.
  • Posture. Promote good posture by providing a pillow for the lower back and a footstool when the child is sitting.
  • Healthy diet. Begin healthy eating habits early to avoid later problems with weight gain.
  • Healthy activities. Encourage participation in appropriate recreational activities, such as swimming or bicycling, but avoid sports that involve collision or impact, such as football, diving or gymnastics.
  • Coping and support. If a child has dwarfism, a number of steps to help him or her cope with challenges and function independently:
  • Seek help. Organizations provides social support, information about disorders, advocacy opportunities and resources. Many people with dwarfism stay actively involved in this organization throughout their lives.
  • Modify the home. Make changes in the home, such as putting specially designed extensions on light switches, installing lower handrails in stairways and replacing doorknobs with levers.
  • Provide personal adaptive tools. Everyday activities and self-care can be a problem with limited arm reach and problems with dexterity. An occupational therapist also may be able to recommend appropriate tools for home and school use.
  • Talk to educators. Talk to school personnel about what dwarfism is, how it affects the child, what needs the child may have in the classroom and how the school can help meet those needs.
  • Talk about teasing. Encourage the child to talk to you about his or her feelings, and practice responses to insensitive questions and teasing.
  • If the child tells you that bullying occurs in school, seek help from the child’s teacher, principal or the school guidance counselor and ask for a copy of the school’s policy on bullying.

Complications of Dwarfism

Complications of dwarfism-related disorders can vary greatly, but some complications are common to a number of conditions.

Disproportionate dwarfism

  • The characteristic features of the skull, spine and limbs shared by most forms of disproportionate dwarfism result in some common problems.
  • Delays in motor skills development, such as sitting up, crawling and walking.
  • Frequent ear infections and risk of hearing loss.
  • Bowing of the legs.
  • Difficulty breathing during sleep (sleep apnea).
  • Pressure on the spinal cord at the base of the skull.
  • Excess fluid around the brain (hydrocephalus).
  • Crowded teeth
  • Progressive severe hunching or swaying of the back with back pain or problems breathing
  • Narrowing of the channel in the lower spine (spinal stenosis), resulting in pressure on the spinal cord and subsequent pain or numbness in the legs
  • Arthritis
  • Weight gain that can further complicate problems with joints and the spine and place pressure on nerves

Proportionate dwarfism

  • With proportionate dwarfism, problems in growth and development often result in complications with poorly developed organs. For example, heart problems often present in Turner syndrome can have a significant effect on health.
  • An absence of sexual maturation associated with growth hormone deficiency
  • Turner syndrome affects both physical development and social functioning.
  • Pregnancy: Women with disproportionate dwarfism may develop respiratory problems during pregnancy. A C-section (cesarean delivery) is almost always necessary because the size and shape of the pelvis doesn’t allow for successful vaginal delivery.
  • Public perceptions
  • Most people with dwarfism prefer not to be labeled by a condition. However, some people may refer to themselves as dwarfs or little people.
  • People of average height may have misconceptions about people with dwarfism. And the portrayal of people with dwarfism in modern movies often includes stereotypes.
  • Misconceptions can impact a person’s self-esteem and limit opportunities for success in school or employment.
  • Children with dwarfism are particularly vulnerable to teasing and ridicule from classmates. Because dwarfism is relatively uncommon, children may feel isolated from their peers.

Dwarfism (Panhypopituitarism) Read More »

acromegaly and gigantism

Acromegaly & Gingatism (Hyperpituitarism)

Acromegaly/Gigantism (Hyperpituitarism) 

Acromegaly and Gigantism are conditions that result from hyperpituitarism, which is the excessive secretion of growth hormone (GH) by the pituitary gland.

Acromegaly and gigantism can also be referred to as hyperpituitarism and the most common cause is prolonged hypersecretion of growth hormone (GH), usually by a hormone-secreting pituitary tumour. As the tumour increases in size, compression of nearby structures may lead to: hyposecretion of other pituitary hormones of both the anterior and posterior lobes damage to the optic nerves, causing visual disturbances.

  • Gigantism occurs when there is an overproduction of GH in children or adolescents before the closure of the growth plates in bones. This leads to excessive growth in height and overall large stature.
  • Acromegaly occurs when GH overproduction happens in adulthood, after the growth plates have closed. Instead of growing taller, individuals with acromegaly experience abnormal growth of the hands, feet, and facial features, leading to a distinct appearance.

The effects of excess GH include:
>  excessive growth of bones
>  enlargement of internal organs
>  formation of excess connective tissue
>  enlargement of the heart and raised blood pressure
>  reduced glucose tolerance and a predisposition to diabetes mellitus.

Growth hormone stimulates skeletal and soft tissue growth. Growth hormone (GH) excess therefore produces gigantism in children and acromegaly in adults.

Gigantism occur before fusion of the diaphysis and an individual increases in height
reaching 7-8 feet.
Acromegaly occur after fusion of the diaphysis with the epiphysis and there is enlargement of the acral parts
Both are caused due to a pituitary tumor in almost all cases.

Pathophysiology and clinical manifestations of acromegaly/gigantism: 

Pituitary adenomas secrete excessive amounts of GH, which stimulates the production of insulin-like growth factor 1 (IGF-1) in the liver and other tissues. IGF-1 is responsible for the growth-promoting effects of GH. The excessive GH and IGF-1 levels result in tissue overgrowth, primarily affecting bones, cartilage, and soft tissues throughout the body. 

Clinical manifestations Acromegaly and Gigantism:

The clinical manifestations of acromegaly and gigantism are similar and include gradual enlargement and thickening of the bones and tissues. This can lead to changes in facial features, such as;

  • Enlarged hands and feet: The bones and soft tissues in the hands and feet can become enlarged, resulting in larger glove and shoe sizes.
  • Facial changes: This can include a protruding jaw (prognathism), enlarged nose, thickened lips, and a prominent forehead. 
  • Enlarged tongue: The tongue may become larger, potentially causing difficulties with speech and swallowing.
  • Increased size of internal organs: The heart, liver, and other organs may enlarge, leading to various complications.

 The hands and feet may also increase in size. Other manifestations may include 

  • joint pain
  • limited joint mobility
  • increased sweating
  • oily skin
  • sleep apnea, and enlarged nerves.

In children with gigantism, excessive growth can lead to abnormally tall stature. 

Clinical Feature

Acromegaly

Gigantism

Onset

Adulthood (after growth plates have closed)

Childhood or adolescence (before growth plates have closed)

Height

Normal height (since growth plates are closed)

Abnormally increased height (due to prolonged bone growth)

Facial Features

Enlarged jaw, nose, and brow; coarse facial features

Normal facial proportions, but overall larger facial structure

Hand and Foot Size

Enlarged hands and feet, with thickened skin

Large hands and feet relative to body size

Joint Pain

Common due to joint hypertrophy

May occur but less common

Skin Changes

Thick, oily skin; excessive sweating

May have thickened skin

Organ Enlargement (Visceromegaly)

Enlarged organs (heart, liver, kidneys)

Possible, due to overall body enlargement

Cardiovascular Complications

Hypertension, cardiomyopathy

May develop cardiovascular issues due to increased body size

Bone and Soft Tissue Overgrowth

Bone thickening, particularly in the skull and jaw

Generalized overgrowth of bones and soft tissues

Visual Disturbances

Possible due to optic chiasm compression by a pituitary tumor

Possible if tumor compressing optic chiasm

Other Symptoms

Headaches, fatigue, sleep apnea, carpal tunnel syndrome

Headaches, fatigue, may develop other symptoms as they age

Diagnosis and treatment of acromegaly/gigantism: 

Clinical Evaluation:

History: Look for symptoms like:

  • Enlarged hands, feet, and facial features (jaw, nose, forehead)
  • Headaches, vision problems
  • Joint pain and stiffness
  • Sleep apnea, snoring
  • Excessive sweating, fatigue
  • Menstrual irregularities in women
  • Impotence in men
  • Increased ring size, shoe size, hat size
  • Thickened skin, enlarged tongue

Physical Exam: Assess for signs of:

  • Acral enlargement (hands, feet, jaw)
  • Enlarged tongue
  • Hypertrophy of the soft tissues
  • Carpal tunnel syndrome
  • Enlarged organs (liver, spleen)

Biochemical Tests:

  • IGF-1 (Insulin-like Growth Factor-1): The most sensitive and reliable test. Elevated levels are highly suggestive of acromegaly or gigantism.
  • GH levels: Can be measured, but are less reliable than IGF-1 as GH levels fluctuate throughout the day.

Imaging Studies:

  • MRI (Magnetic Resonance Imaging): The gold standard for visualizing the pituitary gland and identifying a tumor.
  • CT (Computed Tomography) scan: Can also be used to assess the pituitary gland, but MRI is preferred.

Investigations:

Pituitary Function Tests:

  • Hormonal evaluation: To assess the function of other pituitary hormones (TSH, ACTH, FSH, LH, prolactin) as other pituitary hormones may be affected by the tumor.

Cardiovascular Evaluation:

  • Echocardiogram: To assess heart size and function, as acromegaly can lead to cardiomegaly and heart failure.
  • Electrocardiogram (ECG): To assess heart rhythm and electrical activity.

Management and Treatment

The primary treatment for acromegaly/gigantism is the surgical removal or reduction of the pituitary adenoma through transsphenoidal surgery.

In cases where surgery is not possible or does not fully resolve the condition, other treatment modalities may include medication (such as somatostatin analogs or GH receptor antagonists) to lower GH levels, radiation therapy to target the tumor, or a combination of these approaches. 

1. Medical Management:

  • Somatostatin Analogues: (e.g., octreotide, lanreotide) are synthetic versions of the naturally occurring hormone somatostatin, which inhibits GH release. They are effective in controlling GH levels and reducing tumor size in some patients.
  • Dopamine Agonists: (e.g., bromocriptine, cabergoline) can be effective in some patients, especially those with GH-secreting tumors that are sensitive to dopamine.
  • Pegvisomant: A GH receptor antagonist that blocks the action of GH at its target tissues. It is effective in reducing GH levels and improving symptoms, but can be associated with liver toxicity.

2. Surgical Management:

  • Transsphenoidal Surgery: This involves removing the pituitary tumor through the nose and sinuses. It can be very effective in treating acromegaly, but it is a major surgery with potential risks.

3. Radiation Therapy:

  • Stereotactic Radiosurgery: This is a non-invasive treatment that delivers a high dose of radiation to the tumor, destroying it gradually. It can be used as a primary treatment or as an adjunct to surgery.

Nursing Care:

  • Patient Education: Educate the patient about acromegaly, its causes, treatments, and potential complications.
  • Symptom Management: Help patients manage symptoms like headaches, joint pain, sleep apnea, and fatigue.
  • Medication Administration: Administer medications as prescribed and monitor for side effects.
  • Monitoring for Complications: Observe signs and symptoms of complications like cardiovascular disease, diabetes, and vision problems.
  • Support and Emotional Care: Provide emotional support and guidance to patients and their families as they adjust to the diagnosis and treatment.
  • Regular Monitoring: Includes regular IGF-1 and GH level monitoring, as well as monitoring for complications.
  • Lifestyle Modifications: Weight management, exercise, and a healthy diet are important for improving overall health and managing complications.
 Nursing interventions for acromegaly/gigantism: 
  1. Monitor and assess the patient’s physical and psychological well-being, including symptoms, vital signs, and emotional state. 
  2.  Educate the patient about the condition, its management, and the importance of treatment compliance. 
  3. Assist in the administration of prescribed medications and monitor for potential side effects. 
  4. Monitor and manage pain, including joint pain and headaches, through appropriate pain management strategies. 
  5. Support the patient in maintaining a healthy lifestyle, including regular exercise and a balanced diet. 
  6. Provide emotional support and counseling to address body image concerns and potential psychosocial challenges. 
  7. Assess and monitor the patient’s endocrine function, including hormonal levels, to evaluate treatment effectiveness and detect any complications. 
  8. Monitor the patient’s cardiovascular health by assessing blood pressure, heart rate, and signs of heart enlargement or dysfunction. 
  9.  Assist with the management of comorbidities that may arise, such as diabetes, hypertension, and sleep apnea. 
  10.  Educate the patient on the importance of regular follow-up appointments, including hormone level monitoring, imaging studies, and other necessary investigations. 
  11. Collaborate with the healthcare team to provide coordinated care and ensure continuity of treatment. 
  12.  Help the patient cope with potential psychological and emotional challenges associated with the condition, such as body image changes, anxiety, and depression. 
  13.  Promote a safe environment by assisting with mobility, falls prevention, and management of joint pain and limited mobility. 
  14.  Encourage the patient to engage in activities that promote overall well-being and quality of life.
  15.  Provide nutritional counseling to ensure a balanced diet that supports bone health.
  16. Foster open communication and a therapeutic relationship with the patient, addressing any concerns or questions they may have.

Complications

  • Sterility in females and importance in males
  • Poor learning ability
  • Lack of sexual development
  • Poor concentration
  • Irritability
  • Heart disease
  • Diabetes mellitus
  • Gallstone
  • Enlargement of internal organs like heart, liver
  • Cancer
  • Polyp formation
Nursing Care Plan for Acromegaly and Gigantism

Assessment

Nursing Diagnosis

Goals/Expected Outcomes

Interventions

Rationale

Evaluation

1. Patient verbalizes anxiety over physical appearance changes (thickened skin, enlarged face, hands, and feet).

Disturbed Body Image related to anxiety over thickened skin and enlargement of face, hands, and feet.

The patient will verbalize acceptance of their appearance and demonstrate behaviors to enhance body image.

– Provide emotional support and counseling to address feelings of self-consciousness.

– Encourage patient participation in grooming and self-care activities.

– Involve the patient in support groups with others experiencing similar conditions.

To reduce anxiety and promote positive coping mechanisms.

Engaging in self-care can enhance self-esteem.

Support groups offer emotional support and shared experiences.

The patient reports reduced anxiety and increased acceptance of physical changes.

2. Patient shows signs of emotional distress, and expresses feelings of helplessness due to changes in appearance.

Ineffective Coping related to change in appearance.

The patient will demonstrate effective coping strategies and verbalize reduced distress.

– Assess the patient’s current coping mechanisms and provide education on effective coping strategies.

– Refer the patient to a psychologist or counselor for additional support.

– Encourage participation in activities that the patient enjoys and finds relaxing.

Understanding current coping methods allows for targeted interventions.

Professional counseling can help the patient develop healthy coping strategies.

Participation in enjoyable activities can reduce stress and improve mood.

The patient demonstrates effective coping strategies and verbalizes reduced emotional distress.

3. Patient reports tingling sensations in the hands and feet, and reduced sensitivity to touch.

Disturbed Sensory Perception related to nerve compression from tissue overgrowth.

The patient will report a reduction in tingling and an improvement in sensory perception.

– Monitor and document changes in sensory perception regularly.

– Educate the patient on the importance of avoiding activities that could lead to injury due to decreased sensation.

– Collaborate with physical therapy to enhance sensory perception.

Regular monitoring helps in identifying worsening or improving conditions.

Educating the patient reduces the risk of injury.

Physical therapy can improve sensory function and prevent complications.

The patient reports reduced tingling and improved sensory perception.

4. Patient reports difficulty sleeping due to soft tissue swelling.

Disturbed Sleeping Pattern related to soft tissue swelling.

The patient will report improved sleep quality and reduced nighttime discomfort.

– Elevate the head of the bed to reduce swelling and improve breathing.

– Encourage the patient to maintain a regular sleep schedule.

– Administer prescribed medications to reduce swelling as needed.

Elevation can help reduce fluid accumulation in tissues.

A regular sleep schedule improves sleep quality.

Medications can help manage swelling and discomfort.

The patient reports improved sleep and reduced nighttime discomfort.

5. Patient shows signs of dehydration (dry skin, decreased urine output).

Fluid Volume Deficit related to increased metabolic demands and soft tissue growth.

The patient will maintain adequate hydration, as evidenced by normal skin turgor and urine output.

– Monitor daily fluid intake and output, and encourage adequate fluid consumption.

– Administer intravenous fluids as prescribed if oral intake is insufficient.

– Educate the patient on the importance of hydration and signs of dehydration to watch for.

Monitoring fluid balance helps prevent complications.

IV fluids provide hydration when oral intake is insufficient.

Education empowers the patient to manage their condition effectively.

The patient maintains normal hydration levels, with normal skin turgor and urine output.

6. Patient expresses anxiety about changes in appearance and possible social implications.

Anxiety related to change in appearance.

The patient will report reduced anxiety and demonstrate relaxation techniques.

– Assess the patient’s level of anxiety and provide reassurance.

– Teach relaxation techniques such as deep breathing and progressive muscle relaxation.

– Encourage open communication about concerns and fears.

Assessing anxiety levels allows for appropriate interventions.

Relaxation techniques help reduce anxiety.

Open communication fosters trust and understanding.

The patient reports reduced anxiety and effectively uses relaxation techniques.

7. Patient shows a lack of understanding about their condition and its management.

Knowledge Deficit related to lack of information about acromegaly/gigantism and its management.

The patient will demonstrate an understanding of their condition and engage in appropriate self-care behaviors.

– Provide comprehensive education about acromegaly/gigantism, including causes, symptoms, and treatment options.

– Encourage the patient to ask questions and participate in care decisions.

– Offer written materials and resources for further learning.

Education empowers the patient to manage their condition effectively.

Involving the patient in care decisions increases adherence to the treatment plan.

Written materials provide ongoing reference and support learning.

The patient demonstrates understanding of their condition and actively participates in their care.

Acromegaly & Gingatism (Hyperpituitarism) Read More »

endocrine system

Endocrine System

Applied Anatomy and Physiology of the Endocrine System

The endocrine system controls the growth of many tissues, like the bone and muscle, and the degree of metabolism of various tissues, which aids in the maintenance of the normal body temperature and normal mental functions.

The endocrine system comprises glands and tissues that produce hormones for regulating and coordinating vital bodily functions, including growth and development, metabolism, sexual function and reproduction, sleep and mood.

Endocrine system is a system of ductless glands, which secrete hormones that are pored in the blood stream to be transported to the target cells.
The endocrine system is composed of the following

  1. Pituitary gland
  2.  Parathyroid gland
  3. Thyroid gland
  4. Adrenal gland
  5. Pancreas
  6. Tests and ovaries

Hormones secreted by these glands act on the specific target tissue away from their site of secretion. Some hormones are protein in nature while others are not.

They act by interacting with specific cell membrane receptors to stimulate the intra cellular Adenylyl cyclase system (membrane-bound enzyme that catalyzes the conversion of Adenosine triphosphate (ATP)-organic compound that provides energy to drive many processes in living cells, such as muscle contraction, nerve impulse to Cyclic adenosine monophosphate (cAMP) – messenger used for intracellular signal induction, which in turn forms ATP to stimulate protein synthesis.

Hormones regulate their own production through a feedback (negative feedback mechanism) system where the increase in concentration of the hormone suppresses its own production.

Structure and function of major endocrine glands: 

The endocrine system consists of several major glands that secrete hormones into the bloodstream. These glands include the pituitary gland, thyroid gland, adrenal glands, and pancreas. 

The endocrine system plays a big role in regulating numerous body functions by releasing hormones, which are chemical messengers, directly into the bloodstream. These hormones travel to target tissues, influencing various physiological activities.

Exocrine vs. Endocrine Glands

Exocrine glands differ from endocrine glands in that they use ducts to transport their secretions, whereas endocrine glands release hormones directly into the bloodstream.

Pituitary Gland: The Master Gland

The pituitary gland, often termed the “master gland,” is a small structure hanging from the base of the brain. It controls other endocrine glands through hormone production, which is regulated by the hypothalamus.

But, hypothalamus is what controls the pituitary gland, making it the master of the master gland 🤣

Pituitary Gland Structure and Function

The pituitary gland is divided into two parts: the anterior and posterior pituitary, each with distinct functions and hormone production.

  • Posterior Pituitary: Produces oxytocin, which stimulates uterine contractions and milk ejection, and antidiuretic hormone (ADH), which helps the kidneys retain water.
  • Anterior Pituitary: Produces several hormones including thyroid-stimulating hormone (TSH), growth hormone (GH), adrenocorticotropin (ACTH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin.

The pituitary gland secretes hormones like; (Anterior lobe)

  •  Adrenocorticotrophic hormone (ACTH)
  • Somatotrophic hormone (STH)/(GH)
  •  Thyroid stimulating hormone (TSH)
  •  Follicle stimulating hormone (FSH)
  •  Luteinizing hormone (LH)’
  •  Melanocyte stimulating hormone (MSH)

The Posterior lobe secretes

  • Anti diuretic hormone (ADH),
  • Vasopressin 
  • Oxytocin.

Secretion of the anterior lobe is under the control of Hypothalamus which secretes regulatory hormones.

Growth hormone stimulates muscular and skeletal growth either by regulating synthesis of somatomedins by the liver or by directly stimulating incorporation of amino acids into proteins.
Hypoglycemia is a potent stimulant of growth hormone release; obesity blunts its release.
Excess secretion of growth hormone after epiphyseal fusion produces acromegaly where as before epiphyseal fusion causes gigantism

Image showing hormones produced by the anterior lobe.

Hormones produced by the anterior pituitary gland
Thyroid Gland

Located in the neck just below the larynx, the thyroid gland consists of two lobes connected by an isthmus. It produces thyroid hormones (T4 and T3) that regulate metabolism and calcitonin, which lowers blood calcium levels.

Parathyroid Glands
Parathyroid Glands

These small glands, usually four in number, are located near the thyroid and regulate calcium levels in the body through the secretion of parathyroid hormone.

Pancreas
Pancreas

The pancreas has both endocrine and exocrine functions, for digestion and blood sugar regulation. The endocrine function occurs in the Islets of Langerhans, which contain alpha, beta, and delta cells.

  • Alpha Cells: Release glucagon to increase blood glucose levels.
  • Beta Cells: Produce insulin, which lowers blood glucose by facilitating its uptake into cells.
  • Delta Cells: Secrete somatostatin, which inhibits both glucagon and insulin.
Adrenal Glands
Adrenal Glands

Situated atop the kidneys, the adrenal glands consist of two parts with distinct functions:

  • Adrenal Medulla: Secretes catecholamines (norepinephrine and epinephrine), which are involved in the sympathetic nervous system’s response to stress.
  • Adrenal Cortex: Produces steroid hormones including glucocorticoids (which increase blood glucose), mineralocorticoids (which regulate sodium and potassium), and androgenic hormones.
Gonads
Gonads

The gonads are the reproductive glands with endocrine functions.

  • Ovaries: Located in the female abdomen, they produce estrogen and progesterone under the control of FSH and LH from the anterior pituitary.
  • Testes: Situated in the male scrotum, they produce sperm and testosterone, promoting male growth and secondary sexual characteristics.

Hormones Produced 

The pituitary gland is divided into two parts: the anterior pituitary and the posterior pituitary, each producing different hormones with distinct functions. 

Anterior Pituitary Hormones
  • Thyroid-Stimulating Hormone (TSH): Stimulates the thyroid gland to produce thyroid hormones (T3 and T4), which regulate metabolism, energy levels, and overall growth and development.
  • Growth Hormone (GH): Promotes growth of body tissues, particularly bones and muscles, by increasing protein synthesis, fat metabolism, and cell division.
  • Adrenocorticotropic Hormone (ACTH): Stimulates the adrenal cortex to release cortisol, a hormone that helps the body respond to stress, maintain blood sugar levels, and regulate metabolism.
  • Follicle-Stimulating Hormone (FSH): In females, it stimulates the growth and maturation of ovarian follicles; in males, it promotes sperm production in the testes.
  • Luteinizing Hormone (LH): In females, it triggers ovulation and the production of progesterone; in males, it stimulates the production of testosterone in the testes.
  • Prolactin: Promotes milk production in the mammary glands after childbirth.
Posterior Pituitary Hormones
  • Oxytocin: Stimulates uterine contractions during childbirth and promotes the ejection of milk during breastfeeding.
  • Antidiuretic Hormone (ADH): Helps the kidneys manage the amount of water in the body by increasing water reabsorption, reducing urine volume, and helping maintain blood pressure.

Endocrine System Read More »

Parkinson's Disease

Parkinson’s Disease

PARKINSON’S DISEASE

Parkinson’s disease is a neurodegenerative disorder characterized by the progressive loss of dopamine-producing cells in a specific region of the brain called the substantia nigra. 

This loss of dopamine leads to abnormal brain activity and the manifestation of various motor and non-motor symptoms. 

Cause of Parkinson’s Disease

The exact cause of Parkinson’s disease remains unclear, but it is believed to involve a combination of genetic and environmental factors. The exact cause of Parkinson’s Disease (PD) is unknown.

A combination of genetics and environmental factors is believed to trigger PD.

Factors that contribute to PD include:
  • Dopamine deficiency: Parkinson’s disease is characterized by the loss of dopamine-producing neurons in the brain. Dopamine is a neurotransmitter that plays a crucial role in movement control, so a deficiency leads to motor symptoms like tremors and rigidity.
  • Loss of norepinephrine: Norepinephrine is another neurotransmitter affected in Parkinson’s disease. It regulates various functions, including blood pressure, heart rate, and mood. Its loss can contribute to non-motor symptoms such as fatigue and changes in blood pressure.
  • The protein alpha-synuclein: This protein can form abnormal clumps called Lewy bodies in the brains of people with Parkinson’s disease. These clumps are thought to damage nerve cells and contribute to the development of the disease.
  • Genetics: While most cases of Parkinson’s disease are not directly inherited, certain genetic mutations can increase a person’s risk of developing the condition.
  • Environmental factors: Exposure to certain environmental toxins, such as pesticides and heavy metals, has been linked to an increased risk of Parkinson’s disease.
  • Mitochondria: Dysfunction of mitochondria (the energy-producing structures within cells) may play a role in Parkinson’s disease by leading to oxidative stress and cell damage in the brain.
Pathophysiology of Parkinson's disease:

Pathophysiology of Parkinson’s disease: 

Parkinson’s disease is a progressive neurological disorder that affects movement. The disease is believed to be caused by the death of dopamine-producing cells in the substantia nigra, a part of the brain that helps control movement.

This leads to a depletion of dopamine, a neurotransmitter that helps regulate movement. The loss of dopamine causes problems with nerve signaling in the brain, which leads to the characteristic symptoms of Parkinson’s disease, such as tremors, rigidity, bradykinesia (slowness of movement), and postural instability. These symptoms arise due to the imbalance of excitatory and inhibitory neurotransmitters in the corpus striatum.

In details;

  1. Initiating Factors: Antipsychotic drugs, encephalitis, and other causes can initiate the process.
  2. Substantia Nigra Affected: These factors affect the substantia nigra (SN), a brain region critical for motor control.
  3. Destruction of Dopaminergic Neurons: Leads to the destruction of dopaminergic neuronal cells within the substantia nigra, located in the basal ganglia.
  4. Depletion of Dopamine: This destruction causes a depletion of dopamine stores, a key neurotransmitter involved in movement.
  5. Degeneration of Nigrostriatal Pathway: The dopaminergic nigrostriatal pathway, which connects the substantia nigra to the corpus striatum, degenerates.
  6. Neurotransmitter Imbalance: An imbalance occurs between excitatory (acetylcholine, Ach) and inhibitory neurotransmitters in the corpus striatum, disrupting normal signaling.
  7. Motor Control Impairment: Results in difficulty controlling and initiating voluntary movements.
  8. Parkinson’s Disease Manifestation: Ultimately leads to the manifestation of Parkinson’s disease, characterized by:
  • Tremors
  • Rigidity
  • Bradykinesia (slowness of movement)
  • Postural changes
The 5 Stages of Parkinson's Disease

The 5 Stages of Parkinson's Disease

1. Stage One: Mild Symptoms on One Side

In the beginning, symptoms are very mild and only affect one side of the body. You might notice a patient has a slight tremor (shaking) in one hand or leg, or some stiffness. One side of their face may also show less expression. At this stage, the person can usually continue with their daily activities without much trouble.

2. Stage Two: Symptoms on Both Sides

The stiffness and tremors now spread to affect both sides of the body. The person's posture may start to change, and they may walk more slowly. Their face might look more "mask-like" with less blinking, and their speech can become softer or slower. Balance is not yet a major problem, but everyday tasks will take longer to complete.

3. Stage Three: Balance Problems Begin

This is the middle stage where loss of balance becomes the main problem. The person's movements are much slower, and falls become more common. They can still be independent in many ways (like dressing and eating), but activities are now more difficult. They might need some help to stay safe.

4. Stage Four: Needing Help to Stand and Walk

At this stage, the symptoms are severe. The person needs help to stand up and walk, and may use a walker or other assistive device. They are no longer able to live alone safely and will need a lot of help with daily care. While they may still be able to stand or walk for short periods, it is very difficult.

5. Stage Five: Full-Time Care Needed

This is the most advanced stage. Severe stiffness in the legs may make it impossible to stand or walk, so the person may be in a wheelchair or bed-bound. They require 24-hour nursing care for all their needs. Some patients may also experience confusion, hallucinations (seeing things that are not there), or dementia.

Clinical Features of Parkinson’s Disease 

1. Motor Symptoms: 

  • Tremors: Tremor present at rest but not during sleep characterized by rhythmic movements of 4 – 5 cycles a second and can occur in the head, facial muscles, limbs, jaw and lips. Micrographic (tiny handwriting) pill rolling character due to movement of the thumb across the palm also occurs. Tremors are increased by emotions.
  • Rigidity: Muscles are stiff with pain in severe cases; rigidity may be continuous or intermittent. Fine limb movements are difficult to perform. Stiffness or resistance in muscles, making movements less fluid and causing muscle pain or discomfort. 
  • Akinesia: Loss or impairment in power of voluntary movement. Bradykinesia (slowness in walking) and hypokinesia (loss of movement): rising from a chair
    becomes difficult and takes several attempts of falling back.
  • Imbalance: Change in gait, tendency to walk forward on toes with small steps may be accelerated. Fascination (work with short steep with no arm swinging) propels patient either forward or backward propulsively until falling is inevitable
  • Postural Instability: Changes in balance ie stooped over posture when up right, difficult in entertaining balance when sited erect and semi flexed arms.  Impaired balance and coordination, resulting in a tendency to stoop, shuffle while walking, and increased risk of falls. 
  • Bradykinesia: This means slowness of movement and speed (or progressive hesitations/halts) as movements are continued. It is one of the cardinal symptoms of Parkinson’s disease (PD). You must have bradykinesia plus at least either tremor or rigidity for a Parkinson’s diagnosis to be considered.

2. Non-Motor Symptoms: 

  • Cognitive Changes: Some individuals with Parkinson’s disease may experience mild cognitive impairment, memory problems, difficulty with executive functions, and in later stages, dementia. 
  • Sleep Disorders: Including insomnia, restless leg syndrome, excessive daytime sleepiness, and rapid eye movement sleep behavior disorder (acting out dreams during sleep). 
  • Autonomic Dysfunction: Symptoms may include orthostatic hypotension (low blood pressure upon standing), constipation, urinary problems, excessive sweating, and sexual dysfunction. 
  • Mood and Behavioral Changes: Depression, anxiety, apathy, and changes in mood or behavior are common in Parkinson’s disease. 
  • Sensory Symptoms: Loss of sense of smell (anosmia) and visual disturbances such as blurred or double vision. 
  • Speech and Swallowing Difficulties: Speaking softly, slurred speech, difficulty swallowing (dysphagia), and drooling may occur. 
  • Pain and Fatigue: Some individuals with Parkinson’s disease may experience pain, muscle cramps, and fatigue.

Diagnosis of Parkinson’s Disease

1. Medical History: The doctor will begin by taking a detailed medical history, including asking about the patient’s symptoms, their duration, and any family history of Parkinson’s disease. 

2. Physical Examination: A thorough physical examination will be conducted to assess motor symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and postural instability. The doctor will also look for other possible causes of these symptoms. 

3. Assessment of Symptoms: The doctor may use standardized rating scales, such as the Unified Parkinson’s Disease Rating Scale (UPDRS), to evaluate the severity of symptoms and track disease progression. 

4. Response to Medication: Parkinson’s disease symptoms often respond positively to dopaminergic medications. The doctor may prescribe a trial of medication, such as levodopa, to observe if there is a significant improvement in symptoms. This can help support the diagnosis of Parkinson’s disease. 

5. Neurological Examination: A neurological examination may be performed to evaluate other neurological signs and rule out alternative diagnoses. 

6. Imaging Studies: While imaging studies are not mandatory for diagnosis, they can help exclude other conditions that mimic Parkinson’s disease. Imaging techniques such as magnetic resonance imaging (MRI) or computed tomography (CT) scans can be used to assess the brain structure and rule out other causes. 

7. Laboratory Tests: There are no specific blood tests to diagnose Parkinson’s disease. However, blood tests may be performed to rule out other medical conditions that can present with similar symptoms. 

 

Management of Parkinson’s Disease 

Unfortunately, as of 2025, Parkinson’s disease can’t be cured, but medicines can help control the symptoms. Medicines often work very well. When medicine is no longer helping, Surgery may be considered.

Aims of Management

  • The primary goal in the management of PD is to treat the symptomatic motor and nonmotor features of the disorder, with the objective of improving the patient’s overall quality of life.
  • To relieve symptoms and maintain functioning to improve quality of life.
Medical Management

1. Levodopa (L-Dopa) – Class: Dopamine Precursor 

  • Dosage: 50 – 125 mg three times daily immediately after meals. 
  • Side Effects: Nausea, vomiting, orthostatic hypotension (low blood pressure upon standing), dyskinesias (involuntary movements), hallucinations, confusion, and sleep disturbances. – Contraindications: Use with caution in patients with a history of psychosis, glaucoma, or melanoma. Avoid concurrent use with non-selective monoamine oxidase inhibitors (MAOIs).

2. Carbidopa-Levodopa – Class: Dopamine Precursor with Decarboxylase Inhibitor 

  • Dosage: The dosage is based on the ratio of carbidopa to levodopa, such as 25/100 8 hourly or 25/250 8 hourly. 
  • Side Effects: Similar to levodopa alone, but carbidopa helps reduce the peripheral side effects of levodopa, such as nausea and vomiting. 

3. Dopamine Agonists – Class: Dopamine Receptor Agonists 

  • Examples: Pramipexole, Ropinirole, Rotigotine 
  • Dosage: The dosage varies depending on the specific medication and individual needs. It is initiated at a low dose and gradually increased. 
  • Side Effects: Nausea, dizziness, orthostatic hypotension, hallucinations, impulse control disorders (such as gambling or hypersexuality), and sleep disturbances. 

4. MAO-B Inhibitors – Class: Monoamine Oxidase-B Inhibitors 

  • Examples: Selegiline, Rasagiline 
  • Dosage: The dosage varies depending on the specific medication. It is usually taken once or twice daily. 
  • Side Effects: Nausea, headache, insomnia, and potential interactions with certain foods and other medications. 
  • Contraindications: Use with caution in patients with a history of psychosis, cardiovascular disease, or peptic ulcer disease. Avoid concurrent use with non-selective MAOIs. 

Specific Nursing Interventions for a patient with Parkinson’s disease: 

1. Promote Safety: 

– Assess the patient’s environment for potential hazards and remove obstacles to prevent falls. 

– Encourage the use of assistive devices such as canes or walkers to improve stability and reduce the risk of falls.

– Provide education to the patient and their caregivers about fall prevention strategies and home safety modifications. 

2. Assist with Mobility: 

– Encourage regular physical exercise and activities tailored to the patient’s abilities to improve mobility, balance, and coordination. 

– Collaborate with physical and occupational therapists to develop a personalized exercise and rehabilitation plan. 

– Use appropriate techniques to assist the patient with transfers, ambulation, and maintaining proper body alignment. 

3. Facilitate Communication: 

– Encourage the patient to speak slowly and clearly, taking breaks between phrases to improve speech clarity. 

– Use visual cues, gestures, or written communication aids to supplement verbal communication. 

– Refer the patient to a speech therapist for evaluation and management of speech difficulties. 

4. Support Swallowing: 

– Provide the patient with a modified diet, including texture modifications or swallowing strategies as recommended by a speech therapist. 

– Offer small, frequent meals to minimize fatigue and aid digestion. 

– Encourage the patient to maintain an upright position while eating and drinking to facilitate swallowing. 

5. Optimize Medication Management: 

– Collaborate with the healthcare team to ensure timely administration of prescribed medications for symptom management. 

– Monitor the patient’s response to medications and report any side effects or changes in symptoms. 

– Educate the patient and caregivers about the importance of medication adherence and the proper administration of medications. 

6. Manage Constipation: 

– Encourage the patient to maintain a high-fiber diet and an adequate fluid intake. 

– Recommend regular exercise and physical activity to promote bowel regularity. 

– Discuss with the healthcare team the use of stool softeners or laxatives if necessary. 

7. Provide Emotional Support: 

– Offer empathetic and compassionate care to address the emotional and psychological impact of the disease. 

– Encourage the patient to express their feelings and concerns, providing a supportive and non-judgmental environment.

– Refer the patient and their caregivers to support groups or counseling services to connect with others facing similar challenges. 

8. Monitor Mental Health: 

– Assess the patient for signs of depression, anxiety, or cognitive impairment. 

– Collaborate with the healthcare team to manage and treat mental health symptoms. 

– Encourage engagement in activities that promote mental stimulation, such as puzzles, reading, or social interactions. 

9. Promote Sleep Hygiene: 

– Educate the patient about good sleep hygiene practices, such as maintaining a regular sleep schedule, creating a comfortable sleep environment, and avoiding stimulants before bedtime. 

10. Educate the Patient and Caregivers: 

– Provide education on Parkinson’s disease, its symptoms, and expected progression. 

– Teach self-management strategies, including medication management, exercise, and symptom recognition. 

– Inform the patient and caregivers about available community resources and support services. 

Possible Nursing Diagnosis 

 

1. Impaired Physical Mobility related to bradykinesia and rigidity as evidenced by inability to initiate movement, staying in the same position for long and needing support to carry out voluntary movement. 

– Explanation: The characteristic motor symptoms of Parkinson’s disease, such as bradykinesia, rigidity, and postural instability, can significantly impair the patient’s ability to move, walk, and perform daily activities independently. Observation of the patient’s gait abnormalities, reduced range of motion, and difficulty with motor tasks can provide evidence for this diagnosis. 

2. Risk for Falls related to tremors and orthostatic hypotension: 

– Explanation: Parkinson’s disease can increase the risk of falls due to postural instability, gait disturbances, and reduced coordination. The patient may exhibit shuffling gait, decreased arm swing, and a stooped posture. History of falls, presence of orthostatic hypotension, and environmental hazards in the patient’s living area can further support this diagnosis. 

3. Impaired Swallowing related to muscle weakness involved in swallowing as evidenced by difficulty in swallowing, choking during eating, coughing and food sticking in the throat(verbalisation/facial grimace) :

– Explanation: Parkinson’s disease can lead to dysphagia (difficulty swallowing) due to muscle weakness, impaired coordination, and decreased mobility of the muscles involved in swallowing. The patient may exhibit prolonged meal times, coughing or choking during meals, or complaints of food sticking in the throat. Evaluation by a speech therapist and observations during meals can provide evidence for this diagnosis. 

4. Risk for Impaired Verbal Communication related to speech muscle involvement:

 – Explanation: Parkinson’s disease can affect the muscles involved in speech production, leading to reduced volume, slurred speech, and monotone voice. The patient may demonstrate difficulty in articulating words and expressing thoughts. Assessment by a speech therapist and observation of the patient’s speech patterns can support this diagnosis. 

5. Risk for Impaired Skin Integrity related to immobility, incontinence: 

– Explanation: The combination of bradykinesia, rigidity, and postural instability in Parkinson’s disease can lead to decreased mobility and changes in body alignment. These factors, along with sensory disturbances, can increase the risk of pressure ulcers and skin breakdown. Observation of the patient’s skin condition, areas of pressure, and assessment of skin integrity can provide evidence for this diagnosis. 

 

 Surgical Management of Parkinson’s disease.

Deep Brain Stimulation (D.B.S):

  • Is a surgical procedure in which electrodes are placed in specific areas of the brain, electrodes are connected to a generator which is programed to send electrical pulses to the brain.
  • The procedure may help to alleviate the following symptoms; tremor, rigidity, stiffness & slowed movement

Facial Nerve Decompression Surgery

  • Management of acute facial paralysis may involve facial nerve decompression surgery in cases of virally-induced facial paralysis (Bell’s palsy, Ramsay-Hunt syndrome) or primary facial nerve repair/grafting in cases of resection or transection of the facial nerve
Facial Nerve Decompression Surgery
Nursing care
  • Perform motion exercises to all joints 3 time a day, massage skeletal muscles to relieve stiffness and use a broad base support when ambulating.
  • Advise patient care givers to avoid pyridoxine protein food and alcohol when using levodopa
  •  Modify home environment to remove hazards and alert the patient on effects of stress, heat and excitement
  • Avoid staying in one position for a long time and try walking with hand clasped behind.
  • Motor patient weight weekly, follow plans for small frequent meals and avoid eating high protein meals at medication time. Ensure adequate fiber and fluid intake.
  • Perform exercise voice regulation by singing or reading loud.
  • Monitor sleep pattern, thought disorders and hallucination.
  • Respond promptly to the urge of urination, defecation and ensure emptiness. Use stool softeners if needed, keep urinal at bedside and monitor bowel habits.
  • Avoid carpets and rugs on floor as a patient sticks on them, use walking aids and offer shoes that are easy to put with smooth soles on to the patient.
  • Alternative medicine i.e massage, tai chi , yoga, pet therapy ,meditation
  • Joining support groups

Diagnosis of Parkinson’s Disease

1. Medical History: The doctor will begin by taking a detailed medical history, including asking about the patient’s symptoms, their duration, and any family history of Parkinson’s disease. 

2. Physical Examination: A thorough physical examination will be conducted to assess motor symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and postural instability. The doctor will also look for other possible causes of these symptoms. 

3. Assessment of Symptoms: The doctor may use standardized rating scales, such as the Unified Parkinson’s Disease Rating Scale (UPDRS), to evaluate the severity of symptoms and track disease progression. 

4. Response to Medication: Parkinson’s disease symptoms often respond positively to dopaminergic medications. The doctor may prescribe a trial of medication, such as levodopa, to observe if there is a significant improvement in symptoms. This can help support the diagnosis of Parkinson’s disease. 

5. Neurological Examination: A neurological examination may be performed to evaluate other neurological signs and rule out alternative diagnoses. 

6. Imaging Studies: While imaging studies are not mandatory for diagnosis, they can help exclude other conditions that mimic Parkinson’s disease. Imaging techniques such as magnetic resonance imaging (MRI) or computed tomography (CT) scans can be used to assess the brain structure and rule out other causes. 

7. Laboratory Tests: There are no specific blood tests to diagnose Parkinson’s disease. However, blood tests may be performed to rule out other medical conditions that can present with similar symptoms. 

Complications of Parkinson’s Disease 

1. Falls and Fall-related Injuries:

– Due to impaired balance, postural instability, and motor symptoms, individuals with Parkinson’s disease are at an increased risk of falls. Falls can result in injuries such as fractures, head trauma, and soft tissue damage. 

2. Dysphagia and Aspiration Pneumonia: 

– Parkinson’s disease can lead to difficulty swallowing (dysphagia), which increases the risk of food or liquid entering the airway (aspiration). Aspiration pneumonia, a lung infection caused by inhaling foreign material, is a potential complication of dysphagia. 

3. Psychiatric and Mood Disorders: 

– Depression, anxiety, and apathy are common psychiatric conditions that can occur in Parkinson’s disease. These mood disorders can significantly impact the patient’s quality of life and may require treatment and psychological support. 

4. Cognitive Impairment and Dementia: 

– As Parkinson’s disease progresses, some individuals may develop cognitive impairment, including problems with memory, attention, and executive functions. In some cases, this can progress to Parkinson’s disease dementia, which affects thinking, judgment, and daily functioning. 

5. Sleep Disorders: 

– Parkinson’s disease is associated with various sleep disturbances, such as insomnia, restless leg syndrome, and rapid eye movement (REM) sleep behavior disorder. These sleep disorders can lead to excessive daytime sleepiness, fatigue, and overall reduced quality of sleep. 

6. Medication-related Complications: 

– Long-term use of medications for Parkinson’s disease, such as levodopa, can lead to complications known as motor fluctuations and dyskinesias. Motor fluctuations are changes in the response to medication, resulting in periods of good symptom control (on periods) and periods of poor symptom control (off periods). Dyskinesias are involuntary, abnormal movements that can occur during certain periods.

Nursing Care Plan: Parkinson’s Disease

Assessment

Nursing Diagnosis

Goals/Expected Outcomes

Interventions

Rationale

Evaluation

Patient presents with resting tremors, bradykinesia, rigidity, and postural instability. Difficulty initiating voluntary movements.

Impaired Physical Mobility related to muscle rigidity and bradykinesia as evidenced by difficulty walking, shuffling gait, and tremors.

– Patient will demonstrate improved mobility and engage in physical activities with minimal assistance. 

– Patient will perform range-of-motion (ROM) exercises daily. 

– Patient will maintain safety while ambulating.

1. Encourage regular physical activity, including passive and active ROM exercises. 2. Provide assistive devices (walker, cane) as needed. 

3. Teach the patient to use the “rocking” technique to initiate movement. 

4. Educate on maintaining an upright posture and taking large, deliberate steps. 

5. Collaborate with a physical therapist for mobility training.

1. Helps prevent stiffness and maintain joint flexibility. 

2. Promotes independence and reduces fall risk. 

 

3. Overcomes movement initiation difficulties. 

 

4. Improves gait and reduces the risk of falls. 

5. Enhances mobility and functional ability.

– Patient engages in physical activity with minimal assistance. 

– Patient reports improved mobility. 

– Patient remains free from falls and injuries.

Patient reports difficulty holding utensils, dressing, and writing. Increased time required for daily tasks. (Dressing, Eating, Grooming) 

Decreased Self-Care Deficit syndrome related to bradykinesia and tremors as evidenced by inability to button clothes, feed self, or use utensils effectively.

– Patient will demonstrate improved ability to perform self-care activities with minimal assistance. 

– Patient will use adaptive devices to enhance independence. 

– Patient will maintain personal hygiene and grooming.

1. Encourage the use of adaptive utensils and clothing with Velcro fasteners. 

2. Allow extra time for the patient to complete tasks. 

3. Provide cues and step-by-step instructions for self-care activities. 

4. Encourage family involvement in assisting the patient as needed. 

5. Refer to an occupational therapist for fine motor skill training.

1. Facilitates independence despite motor difficulties. 

 

2. Reduces frustration and promotes dignity. 

 

3. Supports cognitive function and task completion. 

4. Ensures patient receives necessary support while promoting autonomy. 

5. Helps improve the patient’s ability to perform daily activities.

– Patient demonstrates improved ability to dress, eat, and groom. 

– Patient uses adaptive devices effectively. 

– Patient experiences less frustration with self-care.

Patient exhibits soft, monotone speech, masked facial expression, and difficulty swallowing.

Impaired Verbal Communication related to muscular rigidity and bradykinesia as evidenced by slow speech, decreased voice volume, and difficulty articulating words.

– Patient will use alternative communication methods as needed. 

– Patient will engage in speech therapy exercises. 

– Patient will demonstrate improved ability to express needs.

1. Encourage the patient to speak slowly and exaggerate pronunciation. 

2. Suggest deep breathing exercises to strengthen vocal cords. 

3. Use communication aids such as writing boards or voice amplifiers. 

4. Encourage speech therapy to improve articulation and voice control. 

5. Provide a calm, quiet environment to enhance communication.

1. Helps improve clarity of speech. 

2. Strengthens respiratory muscles and voice projection. 

 

3. Compensates for verbal communication difficulties. 

4. Enhances the ability to communicate effectively. 

5. Reduces frustration and improves comprehension.

– Patient reports improved ability to communicate. 

– Patient uses communication aids effectively. 

– Patient participates in speech therapy sessions.

Patient has difficulty swallowing, risk of aspiration, and reports choking episodes.

Inadequate nutritional intake related to impaired swallowing (dysphagia) as evidenced by coughing, drooling, and difficulty swallowing food and liquids.

– Patient will swallow safely without signs of aspiration. 

– Patient will maintain adequate nutritional and hydration status. 

– Patient will use modified diet strategies to prevent aspiration.

1. Assess swallowing ability and risk for aspiration. 

2. Position patient upright (90-degree angle) during meals and for at least 30 minutes after eating. 

3. Encourage small, frequent meals with thickened liquids if needed. 

4. Teach patient to use the “chin tuck” technique while swallowing. 

5. Refer to a speech therapist for swallowing evaluation and therapy.

1. Identifies patients at high risk for aspiration. 

 

2. Promotes safe swallowing and reduces aspiration risk. 

 

3. Prevents choking and maintains adequate nutrition. 

 

4. Helps direct food away from the airway. 

 

5. Enhances swallowing ability and safety.

– Patient swallows safely without choking or aspiration.

 – Patient maintains adequate nutritional intake. 

– Patient follows recommended swallowing techniques.

Patient expresses sadness, frustration, and social withdrawal due to disease progression.

Chronic confusion related to chronic illness and functional decline as evidenced by social isolation, low mood, and frustration with self-care difficulties.

– Patient will verbalize feelings and express emotions appropriately. 

– Patient will participate in social activities as tolerated. 

– Patient will demonstrate coping strategies to manage frustration.

1. Encourage the patient to express emotions and frustrations. 

2. Provide emotional support and active listening. 

3. Encourage participation in support groups or therapy. 

4. Promote enjoyable activities that the patient can engage in despite limitations. 

5. Monitor for signs of severe depression or suicidal thoughts and refer to a mental health professional if needed.

1. Helps the patient process emotions and reduce distress. 

 

2. Provides reassurance and support. 

 

3. Promotes socialization and reduces isolation. 

 

4. Encourages engagement in life despite limitations. 

 

5. Ensures early intervention for severe depression.

– Patient reports improved mood and emotional well-being.

 – Patient engages in social activities.

 – Patient verbalizes coping strategies effectively.

NANDA 2024-25

Nursing Concerns in Parkinson’s Disease:

Risk of Falls:

Concern for the patient’s increased risk of falls due to impaired balance and coordination.

Implementation of fall prevention strategies and regular assessments of gait and stability.

Functional Independence:

Concern for the preservation of the patient’s functional independence.

Promotion of activities that enhance independence in daily living.

Psychosocial Well-being:

Concern for the patient’s mental health and emotional well-being.

Regular assessment of mood, addressing any signs of depression or anxiety.

Communication Difficulties:

Concern for potential communication challenges.

Monitoring the patient’s ability to express needs and facilitating communication support as required.

Nutritional Status:

Concern for maintaining adequate nutrition.

Regular assessments of the patient’s nutritional intake and collaboration with dietitians to address any deficits.

 

Parkinson’s Disease Read More »

BELL’S PALSY (FACIAL NERVE PALSY)

BELL’S PALSY (FACIAL NERVE PALSY)

BELL’S PALSY (FACIAL NERVE PALSY)

Bell’s Palsy is a disorder characterized by disruption of the motor branch of the facial nerve (CN VII) or paralysis of one side of the face in absence of stroke.

Bell’s palsy is a type of facial paralysis that results in a temporary inability to control the facial muscles on the affected side of the face due to compression of the seventh cranial nerve.

The onset is mostly rapid and unilateral.

Sir Charles Bell, Scottish Surgeon, first described in early 1800’s based on trauma to facial nerves

Causes of Bell’s Palsy

The exact cause is unknown but can be triggered by bacterial or viral infections like :

  • Herpes simplex, Herpes zoster and epstein barr virus.
  • HIV
  • Sarcoidosis, which is the growth of tiny collections of inflammatory cells in different parts of the body
  • Lyme disease (bacterial infection caused by infected ticks)

It is also believed to occur due to localized inflammatory reactions of the facial nerve at the stylomastoid foramen.

  • Demyelination of the nerve can trigger bell’s palsy.
Pathophysiology of Bell’s Palsy

Pathophysiology of Bell’s Palsy

The facial nerve has motor nerves that innervate/supply the muscles of expression on the face and sensory that supplies the tongue. Disruption of the nerve leads to rapid weakening or paralysis of the facial muscles on one side creating a mask-like appearance (angry face). Paralysis develops in 24-36 hours and the eye of the affected side tears constantly.
The condition accompanies an outbreak of herpes vesicles around the ear.

  1. Etiology: The initial cause/factor is an inflammation of the facial nerve.
  2. Compression and Occlusion: The inflamed and swollen nerve gets compressed, potentially leading to damage or blockage of its blood supply.
  3. Ischemia: This compression results in reduced blood flow, causing ischemia (lack of oxygen and nutrients).
  4. Necrosis: The lack of blood supply leads to nerve tissue death (necrosis).
  5. Paralysis: The death of the facial nerve ultimately causes paralysis of the facial muscles.
Signs and symptoms of Bells palsy (1)

Signs and symptoms of Bell’s palsy

  1. Facial Weakness: Drooping of the face and difficulty in performing facial expressions like smiling.
  2. Eye-related Issues: Inability to close the affected eye, leading to dry eyes, and the eye may fail to roll upward.
  3. Drooling and Speech Difficulties: Dribbling of saliva from the affected mouth angle, and speech difficulties due to muscle weakness.
  4. Challenges in Eating: Difficulty in closing the affected eye may result in food collecting between teeth and cheeks on the affected side.
  5. Whistling Difficulty: Inability to whistle due to muscle weakness on the affected side.
  6. Bell’s Sign: Failure of the eye to close and roll upward on the affected side.
  7. Mouth Deviation: Deviation of the mouth toward the normal side.
  8. Loss of Taste: Unilateral loss of taste sensation.
  9. Pre-paralysis Symptoms: Pain behind the ear before facial paralysis, accompanied by fever, tinnitus, or hearing difficulty.
  10. Muscle Twitches: Facial muscles may experience involuntary twitches.
  11. Dry Eyes and Mouth: Reduced tear and saliva production leading to dry eyes and mouth.
  12. Headaches: Individuals may experience headaches, possibly related to facial muscle tension.
  13. Sensitivity to Sound: Increased sensitivity to sound may be observed.

Diagnostic Evaluation of Bell’s Palsy

Diagnosis is often based on symptoms, ruling out other causes of paralysis like a stroke.

  1. No Definitive Test: No specific test confirms Bell’s Palsy; diagnosis relies on clinical evaluation.
  2. History of Onset of Symptoms: The patient’s experience, including the timing and progression of symptoms, is a key factor in diagnosing Bell’s palsy.
  3. Observation and Examination: Careful observation of the patient’s facial movements helps confirm the diagnosis. This includes assessing upper and lower facial weakness by observing actions like closing the eyes, lifting eyebrows, smiling, and frowning.
  4. Neurological Examination: A thorough neurological examination is conducted to assess the patient’s facial motor capacity. This involves testing the ability to perform facial movements, such as closing the eyes, lifting the eyebrows, smiling, and frowning.
  5. Blood Tests: Blood tests are needed only to rule out other conditions that might cause similar symptoms. These tests examine for viral infections or other risk factors known to be associated with Bell’s palsy.
  6. Electromyography (EMG): This test measures the electrical activity of the facial muscles when stimulated. EMG helps to confirm the presence and severity of nerve damage. It also aids in differentiating Bell’s palsy from a stroke.
  7. Imaging Studies (CT or MRI): Computed tomography (CT) or magnetic resonance imaging (MRI) are used to visualize the affected area and rule out any abnormalities or causes of pressure on the facial nerve. These studies are particularly helpful in excluding other potential causes, such as a brain tumor or a stroke.

Complications of Bell’s Palsy:

  • Malnutrition: Difficulty in eating and drinking due to facial muscle weakness can lead to malnutrition.
  • Psychological Withdrawal: Changes in facial appearance may cause psychological withdrawal and social challenges.
  • Dehydration: Reduced ability to close the affected eye can lead to excessive tear evaporation, contributing to dehydration.
  • Muscle Stretching and Facial Spasms: Prolonged muscle weakness may result in muscle stretching and facial spasms.
  • Synkinesis: Involuntary contraction of certain muscles while attempting to move others, leading to uncoordinated facial movements.
  • Excessive Dryness in Eyes: Inability to close the eye properly may cause excessive dryness, increasing the risk of eye infections and potential blindness.
  • Mucous Membrane Trauma: Difficulty in maintaining normal oral and nasal moisture can lead to mucous membrane trauma.
  • Corneal Abrasion: Insufficient eye protection may result in corneal abrasion, posing a risk to eye health.
  • Facial Spasms and Contractures: Persistent facial spasms and contractures can impact facial muscle function and appearance.
  • Changes in Appearance: Facial asymmetry and changes in appearance may contribute to psychological distress.
  • Speech Difficulties: Impaired muscle coordination may lead to difficulties in articulation and speech.
  • Chronic Eye Issues: Long-term complications may include chronic eye problems and discomfort.
Management of Bell’s Palsy

Management of Bell’s Palsy

There is no specific treatment of the condition and hospitalization is not required;

Aims of management.

  • Reduce Inflammation and Nerve Damage: This involves controlling the inflammation of the facial nerve, preventing further damage, and promoting nerve regeneration.
  • Preserve Facial Function: The goal is to minimize the severity and duration of facial paralysis and to prevent permanent facial muscle weakness.
  • Reduce Pain and Discomfort: Pain, especially in the ear or behind the ear, is common in Bell’s palsy. Pain management is important for the patient’s well-being.

MEDICAL MANAGEMENT

Medications:

1. Corticosteroids: The drugs of choice. Prednisone, a steroid medication, is often prescribed to reduce inflammation and swelling of the facial nerve.

  • Prednisone may be started immediately!
  • Best if initiated before paralysis is complete
  • Taper off over 2 weeks(tapering is the process of stopping all opioids or reducing opioids quickly over a few days or weeks, decreasing the dose by 25% to 50% to 75% to 100%)
  • Analgesics e.g. ibruprofen may be needed for pain

2. Antiviral Medications: Antiviral medications, such as Acyclovir (Zovirax) or famciclovir, because HSV is implicated in 70% of cases. They are sometimes prescribed, particularly if a viral infection is suspected.

3. Analgesics: Over-the-counter or prescription pain medications are used to manage pain and discomfort.

Facial Exercises: Facial exercises are an essential part of Bell’s palsy management, particularly after the initial inflammatory phase. These exercises aim to improve muscle strength and coordination, minimize muscle atrophy, and help regain facial function.

Examples of Conventional Exercises:

  • Eye Exercises: Closing the eye tightly, blinking repeatedly, and gently massaging the eyelids.
  • Brow Exercises: Raising the eyebrows, furrowing the brow, and moving the eyebrows from side to side.
  • Mouth Exercises: Smiling broadly, pursing the lips, puffing out the cheeks, and blowing air out of the mouth.
  • Chin Exercises: Moving the jaw side to side, clenching and unclenching the jaw.
  • Facial Massage: Gently massaging the affected side of the face to improve circulation and muscle tone.

Other Therapies:

  • Physical Therapy: A physical therapist can provide personalized facial exercise programs and teach techniques to improve facial muscle function.
  • Occupational Therapy: Occupational therapists can help with activities of daily living, such as eating, grooming, and communication, and can recommend adaptive strategies for coping with facial weakness.
  • Speech Therapy: Speech therapists can help address speech problems that may arise from facial paralysis, such as slurred speech or difficulty articulating words.

Surgery: Surgical intervention is rarely necessary for Bell’s palsy. In cases of persistent facial paralysis, nerve grafting or muscle transfers might be considered.

Physiotherapy:

  • Facial Massage: Regular facial massage is crucial for maintaining circulation and keeping the skin supple.Massage should be performed in an upward direction, avoiding downward strokes that can stretch the paralyzed muscles and worsen the condition.
  • Taping/Splinting: These methods help to reduce facial asymmetry by supporting the paralyzed side of the face and encouraging muscle balance. They can be customized by a physical therapist or occupational therapist.
  • Muscle Re-education: Faradic Re-education: This technique uses electrical stimulation to re-educate the facial muscles. It is only suitable for patients who can tolerate sensory stimulation.
  • Visual Feedback Exercises: Encouraging patients to perform facial exercises in front of a mirror allows them to observe their progress and improve their technique. This visual feedback can significantly aid in muscle re-education.

Conventional Exercises which include;

  • Elevate eyebrows, after brushing the forehead.
  • Elevate the corner of the lips (like saying “E”), after brushing the affected side of the face.
  • Close eyes slowly and alternately close one eye at a time.
  • Wrinkle and open the wings of the nose.
  • Open the mouth and say “a”, “o”, and alternate between “e”, “a”, “o”.
  • Smile with and without showing teeth.
  • Wind up the cheeks with closed lips.
  • Read and speak aloud.

Eye Care:

  • It is essential to protect the eye on the affected side. The patient should be advised to wash their eyes regularly with saline solution and wear protective goggles or eye patches to prevent dust, debris, or foreign particles from entering the eye.

Alternative Medicine: There is limited scientific evidence to support the effectiveness of alternative medicine for Bell’s palsy, but some individuals may find relief from:

  • Acupuncture: This involves inserting thin needles into specific points on the body, aiming to stimulate nerves and muscles.
SPECIFIC NURSING CARE;
  1. Pain Relief: Apply a warm, moist sponge to alleviate pain.
  2. Eye Care: Pad the dry eye to prevent excessive dryness and potential complications.
  3. Nutrition: Monitor and support the patient’s nutrition, addressing challenges in eating and drinking.
  4. Physiotherapy and Facial Massage: Implement physiotherapy and facial massage to stimulate facial muscles.
  5. Speech Therapy: Provide speech therapy to address potential speech difficulties.
  6. Support Groups: Encourage the patient to join support groups for emotional well-being.
  7. Facial Symmetry: Utilize a face strap to help symmetrize the lips.
  8. Eye Protection: Advise the patient to stay in warm environments, avoid dust and wind, and use eye protection in dangerous exposures.
  9. Swallowing Precautions: Instruct the patient to sit upright while eating, chew on the non-paralyzed side, consume small portions, and maintain a balanced nutrition intake to prevent complications in swallowing.
  10. Privacy during Meals: Respect the patient’s privacy during mealtime to avoid embarrassment.
  11. Mouth Care: Perform careful mouth care, as food may accumulate between the lip and gingiva.
  12. Muscle Tonus Maintenance: Massage the patient’s face with upward strokes for 5-10 minutes to maintain muscle tone, and encourage self-massage.
  13. Active Exercise: If ready, ask the patient to perform active exercises, such as smiling in front of a mirror.
  14. Eye Protection Outside: Suggest using eye protectors, especially when going outdoors. Sterile eyes

NURSING CARE PLAN FOR A PATIENT WITH BELL’S PALSY

Assessment

Nursing Diagnosis

Goals/Expected Outcomes

Interventions

Rationale

Evaluation

Facial asymmetry with drooping on one side, difficulty in closing the eye, and drooling from the mouth.

Post trauma syndrome related to inflammation of the facial nerve as evidenced by inability to close the eye and drooping of the mouth on one side.

Improve facial muscle strength and function, evidenced by the ability to close the eye and reduced drooling within 2 weeks.

– Teach facial exercises to stimulate muscle function.

– Administer prescribed corticosteroids to reduce inflammation and swelling.

– Encourage the use of assistive devices like eye patches to protect the eye.

– Facial exercises can help stimulate the muscles and improve function. 

– Corticosteroids reduce inflammation, which can relieve nerve compression. 

– Eye protection prevents corneal damage due to dryness.

Patient demonstrates improved ability to close the eye and reduced drooping, indicating improved muscle strength and function.

Patient reports difficulty swallowing and frequently chokes on liquids.

Impaired swallowing related to weakness of facial muscles as evidenced by frequent choking and difficulty swallowing.

Prevent aspiration and improve swallowing ability, evidenced by the ability to swallow liquids without choking.

– Instruct the patient on swallowing techniques, such as chin-tuck during swallowing.

– Offer thickened liquids to reduce the risk of aspiration.

– Position the patient upright during meals and for 30 minutes afterward.

Proper swallowing techniques and thickened liquids can reduce the risk of aspiration. 

– Upright positioning helps gravity assist in swallowing and reduces aspiration risk.

Patient swallows liquids without choking, indicating improved swallowing ability.

Patient reports difficulty in articulating words clearly and being understood by others.

Impaired verbal communication related to facial muscle paralysis as evidenced by difficulty articulating words.

Enhance communication ability, evidenced by the patient being understood by others.

– Provide alternative communication methods, such as writing or using communication boards.

– Encourage the patient to speak slowly and clearly.

– Refer to speech therapy if needed.

Alternative communication methods reduce frustration and improve understanding. 

– Speech therapy can help retrain muscles and improve articulation.

Patient is able to communicate effectively using alternative methods or improved speech clarity.

Patient complains of a dry and irritated eye.

Ineffective Dry eye self-management related to incomplete eyelid closure as evidenced by patient complaints of dryness and irritation.

Prevent corneal damage and reduce discomfort, evidenced by the patient reporting no eye irritation and maintaining eye moisture.

– Administer artificial tears or lubricating eye drops as prescribed.

– Apply an eye patch during sleep to protect the eye.

– Teach the patient to manually close the eyelid periodically.

Lubricating eye drops prevent dryness and irritation. An eye patch protects the cornea during sleep, reducing the risk of damage.

Patient reports no eye irritation and maintains eye moisture, indicating effective prevention of corneal damage.

Patient’s affected side of the face is sensitive, and they report discomfort.

Acute pain related to facial nerve inflammation as evidenced by patient complaints of pain on the affected side.

Reduce pain and discomfort, evidenced by the patient reporting a decrease in facial pain.

– Administer prescribed analgesics to manage pain.

– Apply warm compresses to the affected area to alleviate discomfort.

– Educate the patient on gentle facial massage techniques.

Analgesics relieve pain, warm compresses reduce discomfort, and facial massage can help stimulate circulation and reduce pain.

Patient reports reduced pain and discomfort, indicating effective pain management.

Patient expresses anxiety and emotional distress about their appearance and the sudden onset of facial paralysis.

Excessive Anxiety related to the sudden onset of facial paralysis as evidenced by patient verbalizing concerns about appearance, and presenting with emotional distress.

Reduce anxiety and improve emotional well-being, evidenced by the patient reporting reduced distress and improved coping.

– Provide emotional support and reassurance about the potential for recovery.

– Encourage the patient to express feelings and concerns.

– Refer to counseling or support groups if needed.

Emotional support and reassurance can help reduce anxiety. 

– Counseling or support groups provide a space for the patient to process emotions and learn coping strategies.

Patient reports reduced anxiety and improved emotional well-being, indicating effective emotional support.

NANDA 2024-26

Nursing Concerns for Bell’s Palsy

  1. Risk for Aspiration: Facial weakness can affect swallowing, increasing the risk of aspiration.
  2. Risk for Corneal Abrasion: The inability to close the eye completely can lead to corneal dryness and damage.
  3. Impaired Communication: Facial weakness can make it difficult for the patient to speak clearly.
  4. Disrupted Body Image: The facial paralysis can have a significant impact on the patient’s self-esteem.
  5. Risk for Infection: The affected eye is more susceptible to infection due to dryness and decreased blinking.
  6. Risk for Delayed Recovery: The patient may experience anxiety and frustration due to the slow recovery process.
  7. Risk for Social Isolation: The facial paralysis can make the patient feel self-conscious and withdraw from social interactions.

BELL’S PALSY (FACIAL NERVE PALSY) Read More »

Trigeminal Neuralgia

Trigeminal Neuralgia

TRIGEMINAL NEURALGIA

Trigeminal Neuralgia also known as Tic Douloreuv is a disorder that affects the 5th cranial nerve that causes intense periodic pain in one or more trigeminal nerve branches. Normally affects the 2nd and 3rd branches.

Branches of the Trigeminal Nerve

The trigeminal nerve has 3 divisions i.e

  • The ophthalmic division(v1) that supplies the forehead, eyes, nose, meninges, paranasal sinuses and part of the nasal mucosa.
  • The maxillary division(v2) supplies the upper jaw, teeth, lip, cheeks, hard palate, maxillary sinus and part of the nasal mucosa.
  • The mandibular division(v3) supplies the lower jaw, teeth, lip, buccal mucosa, tongue, part of the external ear and the meninges.

Trigeminal neuralgia most commonly affects the second (V2) and third (V3) branches of the trigeminal nerve.

Causes of Trigeminal Neuralgia:

Causes of Trigeminal Neuralgia:

The exact cause of trigeminal neuralgia is not fully understood; however, factors depend on the subtype. The International Classification of Headache Disorders, Third Edition (ICHD-3) categorizes Trigeminal Neuralgia (TN) into three main types:

1. Classic Trigeminal Neuralgia (Classic TN):

  • This is the most common form of TN.
  • It is characterized by intense, sharp, electric-shock-like pain in the face, affecting the second (maxillary) or third (mandibular) branches of the trigeminal nerve.
  • The primary cause is believed to be compression of the trigeminal nerve by a nearby blood vessel, often an artery.

2. Secondary Trigeminal Neuralgia (Secondary TN):

This type of TN arises as a consequence of another underlying condition, such as:

  • Tumors: A tumor located along the trigeminal nerve can compress and irritate it.
  • Multiple Sclerosis (MS): The demyelination process in MS can damage the nerve fibers, leading to pain.
  • Other Neurological Disorders: Conditions like brainstem stroke or brain aneurysm can also contribute to secondary TN.

3. Idiopathic Trigeminal Neuralgia (Idiopathic TN):

  • This category refers to cases of TN where the underlying cause remains unknown.
  • Despite extensive investigations, no identifiable factor like a blood vessel compression or other neurological condition is found to be responsible.
General causative factors include

  1. Nerve Compression:

    • Explanation:: Compression of the trigeminal nerve by nearby structures, often blood vessels, leading to irritation and pain signals.
    • Example: Blood vessels impinging on the trigeminal nerve, causing compression and neuralgia.

  2. Demyelinating Plaques:

    • Explanation: Damage to the myelin sheath surrounding the trigeminal nerve, disrupting normal nerve function.
    • Example: Demyelination seen in conditions like multiple sclerosis.

  3. Herpes Virus Infection:

    • Explanation: Activation or infection of the trigeminal nerve by the herpes virus, contributing to inflammation and pain.
    • Example: Reactivation of the herpes simplex virus affecting the trigeminal nerve.

  4. Infection of the Teeth and Jaw:

    • Explanation: Infections in the teeth or jaw leading to inflammation and irritation of the trigeminal nerve.
    • Example: Dental infections spreading to the trigeminal nerve branches.

  5. Irritation from Flu-Like Illnesses:

    • Explanation: Inflammatory response due to flu-like illnesses affecting the trigeminal nerve.
    • Example: Increased sensitivity and irritation during or after a viral infection.

  6. Trauma of the Teeth or Jaw:

    • Explanation: Physical injury to the teeth or jaw causing irritation of the trigeminal nerve.
    • Example: Dental trauma resulting in nerve irritation and subsequent neuralgia.

  7. Aneurysm Causing Pressure on the Nerve:

    • Explanation: Enlargement of an artery (aneurysm) putting pressure on the trigeminal nerve.
    • Example: Compression of the nerve by an adjacent aneurysm.

  8. Tumor:

    • Explanation: Presence of a tumor near the trigeminal nerve leading to compression and irritation.
    • Example: Tumor growth impacting the trigeminal nerve.

  9. Arteriosclerotic Changes of an Artery Close to the Nerve:

    • Explanation: Changes in artery walls close to the trigeminal nerve, potentially leading to compression.
    • Example: Arteriosclerosis affecting vessels in proximity to the trigeminal nerve.

Precipitating Factors of Pain:

  1. Light Touch:

    • Explanation: Even gentle touch or breeze on the face triggers severe pain due to the hypersensitivity of the trigeminal nerve.
    • Example: Brushing against the face lightly causing intense pain.

  2. Eating:

    • Explanation: Chewing and the mechanical process of eating can trigger neuralgic pain.
    • Example: Pain occurring during or after meals.

  3. Swallowing:

    • Explanation: The act of swallowing, which involves movement and muscle engagement in the face, can trigger pain.
    • Example: Pain associated with swallowing liquids or food.

  4. Talking:

    • Explanation: Articulating words and facial movements during speech may induce pain.
    • Example: Pain occurring while engaging in conversation.

  5. Sneezing:

    • Explanation: The sudden and forceful nature of sneezing can trigger intense facial pain.
    • Example: Pain experienced during or after sneezing.

  6. Shaving:

    • Explanation: The mechanical action of shaving involving contact with the face can lead to pain.
    • Example: Pain triggered by shaving activities.

  7. Chewing Gum:

    • Explanation: Repetitive jaw movements during gum chewing can aggravate trigeminal neuralgia.
    • Example: Pain associated with chewing gum.

  8. Brushing the Teeth or Washing the Face:

    • Explanation: Activities involving contact with the face, such as brushing teeth or washing, may cause pain.
    • Example: Pain occurring during facial hygiene practices.

  9. Exposure to Wind:

    • Explanation: Sensitivity to environmental factors, such as wind, leading to pain.
    •  Example: Pain triggered by exposure to windy conditions.
Clinical Features of Trigeminal Neuralgia

Clinical Features of Trigeminal Neuralgia:

1. Nature of the Condition:

  • Trigeminal neuralgia is a chronic condition affecting the fifth cranial nerve.

2. Characteristics of Pain:

  • Characterized by unilateral paroxysms of shooting and stabbing pain.
  • Pain typically occurs in the area innervated by the trigeminal nerve branches (ophthalmic, maxillary, mandibular).
  • Most commonly affects the second and third branches.

3. Description of Pain:

  • Pain is often described as a burning, knife-like, or lightning-like shock.
  • Occurs in the lips, upper or lower gums, forehead, or side of the nose.

     

4. Facial Presentation:

  • Presents with severe facial pain.

5. Unilateral Nature:

  • The pain is unilateral, affecting one side of the face.

6. Muscular Involvement:

  • Associated with involuntary contraction of facial muscles.

7. Eye and Mouth Involvement:

  • Can cause sudden closing of the eye or twitching of the mouth.
  • Historically known as tic douloureux, referring to painful facial twitches.

8. Triggers for Pain Episodes:

  • Pain can be spontaneous or initiated by activities such as chewing, talking, or touching the affected side of the face.

9. Impact on Daily Activities:

  • Patients may alter behaviors, such as improper eating, neglect of hygiene, or wearing a cloth over the face.
  • Social withdrawal due to pain-related discomfort.

10 Coping Mechanisms:

  • Excessive sleeping may be adopted as a coping mechanism to deal with pain.

10. Risk of Suicide:

  • There is a risk of suicide due to the disruption of the patient’s lifestyle caused by the intensity of pain.

11. Unpredictable Recurrence:

  • Recurrences are unpredictable, varying in frequency and duration.
  • Episodes can recur for several days, weeks, or months apart.
Pathophysiology of Trigeminal Neuralgia 

Pathophysiology of Trigeminal Neuralgia

Trigeminal neuralgia (TN) is characterized by intense, stabbing, electric shock-like pain in the distribution of one or more branches of the trigeminal nerve (CN V). It is broadly classified into two main forms: classical (idiopathic) and symptomatic (secondary).

Classical (Idiopathic) Trigeminal Neuralgia: In the classical form, a definitive underlying cause is often not identified. However, microvascular compression of the trigeminal nerve near its exit from the brainstem is the most widely accepted etiological factor.

  • Vascular Compression: Aberrant arteries or veins (e.g., superior cerebellar artery) can compress the trigeminal nerve root, leading to demyelination of the nerve fibers. This demyelination disrupts normal nerve function and can cause ectopic impulse generation and aberrant cross-talk between different types of nerve fibers (Aβ, Aδ, and C fibers). The result is the paroxysmal pain characteristic of TN.
  • Gasserian Ganglion Irritation: Some studies suggest that irritation or compression of the Gasserian ganglion, where the three branches of the trigeminal nerve converge, can also contribute to classical TN.
  • Risk Factors: Classical TN is more prevalent in women and individuals over 50 years old.

Symptomatic (Secondary) Trigeminal Neuralgia: This form arises from an identifiable underlying condition that damages or compresses the trigeminal nerve.

  • Space-occupying lesions: Tumors in the cerebellopontine angle (CPA) such as acoustic neuromas, meningiomas, or epidermoid cysts can compress the trigeminal nerve.
  • Demyelination (Multiple Sclerosis): MS plaques in the brainstem can damage the trigeminal nerve, leading to TN. TN is more common in people with MS, and it often presents bilaterally in these individuals.
  • Other Structural Lesions: Aneurysms, arteriovenous malformations, or other vascular abnormalities can compress the nerve.

Differential Diagnosis

When evaluating a patient with suspected trigeminal neuralgia, it’s important to consider other conditions that can cause facial pain. The differential diagnosis includes:

  • Dental Pathology: Toothaches, abscesses, or temporomandibular joint (TMJ) disorders can mimic TN pain.
  • Herpes Zoster: Postherpetic neuralgia following a shingles outbreak can cause persistent facial pain.
  • Nasopharyngeal and Paranasal Pathology: Sinus infections or tumors in the nasal cavity or sinuses can cause facial pain.
  • Cervical Artery Dissection: Although rare, dissection of the internal carotid or vertebral artery can cause facial pain.
  • Giant Cell Arteritis: This inflammatory condition can cause facial pain, particularly in older adults.
  • Cluster Headaches and Migraines: These primary headache disorders can sometimes present with facial pain.
  • Unstable Angina: In rare cases, pain from unstable angina can radiate to the jaw and face, mimicking TN.
  • Trigeminal Neuropathy: Sensory loss or other neurological deficits may indicate a different underlying condition than TN

Investigations and Diagnosis of Trigeminal Neuralgia (TN)

Diagnosing TN primarily relies on a thorough medical history and physical examination, as there is no single definitive test.

1. Detailed Medical History:

  • Pain Description: Ask about the character, intensity, duration, frequency, and triggers of the pain.
  • Onset and Progression: Inquire about when the pain started, how it has changed over time, and whether it’s been getting worse.
  • Previous Medical History: Information on previous illnesses, neurological conditions, or surgeries is relevant. Ask about current medications and supplements.

2. Physical Examination:

  • Neurological Examination: Assess the patient’s reflexes, sensation, and motor function, particularly in the face and trigeminal nerve distribution.
  • Palpation: The doctor may palpate the jaw and face to identify any areas of tenderness or trigger points.

3. Imaging Studies:

  • Magnetic Resonance Imaging (MRI): An MRI scan can help rule out other neurological conditions that can cause facial pain, such as tumors, MS, or vascular malformations.
  • Computed Tomography (CT) Scan: A CT scan can also help visualize the anatomy of the trigeminal nerve and surrounding structures.

Medical Management of Trigeminal Neuralgia:

Aims of Management

  • Control Pain: Reduce the frequency and severity of pain attacks.
  • Improve Quality of Life: Enable individuals to engage in daily activities without significant pain interference.
  • Prevent Complications: Minimize the risk of potential complications such as depression, anxiety, and social isolation.

Pharmacologic Therapy:

1. Anticonvulsants: Carbamazepine (Tegretol) and oxcarbazepine (Trileptal) are the first-line medications for TN.

  • Carbamazepine (Tegretol): Reduces transmission of impulses at nerve terminals, relieving pain. Adult dose at 100mg. Given with meals to minimize side effects.
  • Monitoring and Side Effects: Patients are observed for side effects, including nausea, dizziness, drowsiness, and potential aplastic anemia. Long-term therapy requires monitoring for bone marrow depression.

2. Antidepressants: Tricyclic antidepressants like amitriptyline (Elavil) can also be effective in pain management.

3. Pain Relievers: Over-the-counter pain relievers like acetaminophen (Tylenol) or ibuprofen (Advil) may provide temporary relief.

4. Alternative Medications: Gabapentin and baclofen are utilized for pain management. If pain control remains inadequate, phenytoin (Dilantin) may be added as adjunctive therapy. Baclofen: This muscle relaxant may help reduce muscle spasms and pain.

Surgical Management:

5. Microvascular Decompression: This surgical procedure involves moving the blood vessel that is compressing the trigeminal nerve away from the nerve.

6. Percutaneous Radiofrequency: This procedure uses heat to destroy the trigeminal nerve fibers responsible for pain.

7. Gamma Knife Radiosurgery: Utilizes stereotactic magnetic resonance imaging (MRI) to identify the trigeminal nerve. Followed by gamma knife radiosurgery for precise intervention.

8. Glycerol Injection: A glycerol solution is injected into the trigeminal nerve, interrupting pain signals.

Nursing Management:

9. Identification of Triggers: Assist patients in recognizing triggers for facial pain (e.g., hot or cold stimuli, jarring motions). Teach strategies like using cotton pads and room temperature water for facial care.

10.Oral Hygiene: Instruct patients to rinse their mouths after eating when tooth brushing causes pain. Perform personal hygiene during pain-free intervals.

11. Dietary Guidance: Advise patients to consume food and fluids at room temperature. Suggest chewing on the unaffected side and opting for soft foods.

12. Emotional Well-being: Recognize and address anxiety, depression, and insomnia common in chronic pain conditions. Implement appropriate interventions and referrals.

13. Postoperative Care: Perform neurologic checks to assess facial motor and sensory deficits postoperatively.

14. Eye Care: Instruct patients not to rub the eye if sensory deficits occur post-surgery. Assess for eye irritation or redness and administer artificial tears if prescribed.

15. Physical Therapy: Specific exercises and techniques can help reduce muscle tension and improve facial movement.

16. Eating and Swallowing: Observe patients for any difficulty in eating and swallowing foods of different consistencies.

17. Lifestyle Modifications: Avoiding triggers, maintaining a regular sleep schedule, and reducing stress can help manage TN.

18. Cognitive-Behavioral Therapy (CBT): CBT can teach coping skills for managing pain and stress.

19. Support Groups: Encourage patients to join support groups for emotional and informational support.

Nursing Interventions

Pain Management:

  • Assess the intensity, duration, and triggers of trigeminal neuralgia pain.
  • Administer prescribed medications and monitor their effectiveness.
  • Implement non-pharmacological pain relief strategies, such as cold packs or distraction techniques.
  • Monitor for side effects of pain medications.

Nutritional Support:

  • Assess the patient’s ability to chew and swallow comfortably.
  • Collaborate with a dietitian to develop a nutrition plan that accommodates the patient’s pain and dietary restrictions.
  • Monitor weight changes and signs of malnutrition.

Facial Mobility and Self-Care:

  • Evaluate the impact of pain on facial mobility and self-care activities.
  • Collaborate with occupational therapy to develop strategies for maintaining facial hygiene.
  • Provide assistance as needed for activities affected by pain.

Communication Challenges:

  • Assess the patient’s ability to articulate words during and after painful episodes.
  • Implement communication aids or alternative methods as necessary.
  • Provide emotional support to address potential frustrations related to communication difficulties.

Psychosocial Support:

  • Evaluate the patient’s emotional well-being and coping mechanisms.
  • Offer counseling or refer to support groups to address the psychological impact of chronic pain.
  • Encourage open communication about fears and concerns related to trigeminal neuralgia.

Patient Education:

  • Educate the patient about trigeminal neuralgia, including potential triggers and lifestyle modifications.
  • Provide information on prescribed medications, their purpose, and potential side effects.
  • Discuss strategies for managing pain at home and when to seek medical attention.

Social Interaction:

  • Assess the patient’s social activities and potential limitations due to pain.
  • Encourage social engagement while considering the patient’s comfort level.
  • Provide guidance on how to communicate the condition to friends and family.

Monitoring for Complications:

  • Monitor for signs of complications such as malnutrition, aspiration, or skin breakdown.
  • Collaborate with the healthcare team to address and prevent potential complications.
  • They include Depression, Anxiety, Weight Loss, Social isolation, Sleep disturbances, Decreased facial sensation.

Medication Adherence:

  • Assess the patient’s adherence to prescribed medications.
  • Identify and address any barriers to medication compliance.
  • Educate the patient on the importance of following the prescribed medication regimen.

Regular Follow-up:

  • Schedule regular follow-up appointments to assess the patient’s overall condition and adjust the care plan as needed.
  • Ensure continuity of care and collaboration among healthcare providers.

Nursing care plan for Trigeminal Neuralgia

Assessment

Nursing Diagnosis

Goals/Expected Outcomes

Intervention

Rationale

Evaluation

Patient reports difficulty chewing and swallowing; weight loss of 3 kg in the last month

Risk for imbalanced nutrition: less than body requirements related to difficulty chewing and swallowing

– Maintain adequate nutritional intake within 1 week.

– Patient reports improved ability to eat without pain.

– Assess a patient’s nutritional status (weight, dietary intake).

– Provide soft or pureed foods that are easier to chew and swallow.

– Consult with a dietitian to ensure nutritional needs are met.

– Painful episodes may lead to avoidance of certain foods, potentially resulting in inadequate nutrition.

– Soft foods reduce discomfort during eating.

– A dietitian can help design a nutritionally balanced meal plan.

Patient maintained adequate nutritional intake within 1 week.

Patient reported improved ability to eat without pain.

Difficulty swallowing, reports of choking during meals

Risk for Aspiration related to difficulty in swallowing.

– Prevent aspiration during meals within 24 hours.

– Patient swallows without difficulty or choking.

– Assess swallowing ability before each meal.

– Position the patient upright during meals and 30 minutes after.

– Provide thickened liquids to reduce the risk of aspiration.

– Facial pain may compromise the patient’s ability to swallow effectively, increasing the risk of aspiration.

– Upright positioning reduces the risk of aspiration.

– Thickened liquids are easier to control during swallowing.

Prevent aspiration during meals within 24 hours

Patient swallows without difficulty or choking

Patient remains alone and avoids social interactions

Social Isolation related to fear of pain during social interactions as evidenced by patients remaining alone and indoors.

– Reduce social isolation within 2 weeks.

– Patient participates in at least one social activity.

– Encourage the patient to express feelings about pain and social isolation.

– Refer the patient to a support group for individuals with chronic pain.

– Plan gradual exposure to social situations, starting with a trusted friend or family member.

– Anticipation of painful episodes may lead to withdrawal from social activities, increasing the risk of social isolation.

– Expressing feelings can help reduce the emotional burden of isolation.

– Support groups provide emotional support and understanding.

– Patient reports feeling less isolated.

– Participates in social activities without significant fear of pain.

Patient stutters and struggles to articulate words during conversation

Impaired Communication related to difficulty articulating words as evidenced by patient stuttering while talking.

– Improve communication within 1 week.

– Patient articulates words more clearly.

– Assess the extent of communication difficulties.

– Provide alternative communication methods (e.g., writing, gestures).

– Encourage the patient to speak slowly and take breaks when needed.

– Painful episodes may affect the patient’s ability to articulate words clearly, impacting communication.

– Alternative methods ensure communication needs are met.

– Speaking slowly and taking breaks can reduce frustration and pain.

– Patient articulates words more clearly.

– Uses alternative communication methods effectively.

Patient reports difficulty sleeping, frequent awakenings due to pain

Altered Sleep Pattern related to trigeminal neuralgia pain disrupting normal sleep cycles as evidenced by patient verbalizing difficulty getting sleep.

– Improve sleep quality within 1 week.

– Patient reports sleeping for at least 6 hours uninterrupted.

– Assess the impact of pain on sleep patterns.

– Encourage a bedtime routine with relaxation techniques (e.g., warm bath, deep breathing).

– Administer prescribed pain medication 30 minutes before bedtime.

– Chronic pain may interfere with the patient’s ability to achieve restful sleep, potentially leading to altered sleep patterns.

– Relaxation techniques can promote sleep.

– Pain medication can reduce pain levels and improve sleep quality.

– Patient reports improved sleep quality.

– Sleeps for at least 6 hours without interruption.

Patient appears self-conscious, wears concealing clothes

Disturbed Body Image related to altered facial expressions and communication difficulties as evidenced by patient putting on concealing clothes.

– Improve body image within 2 weeks.

– Patient expresses acceptance of appearance and interacts more confidently.

– Encourage the patient to express feelings about body image.

– Provide positive reinforcement and support during social interactions.

– Refer to a counselor if needed to address self-esteem issues.

– Changes in facial appearance and communication challenges may contribute to feelings of decreased self-esteem.

– Expressing feelings can help process negative emotions.

– Counseling can provide strategies to improve self-esteem.

– Patient expresses acceptance of appearance.

– Interacts more confidently in social settings.

Trigeminal Neuralgia Read More »

Applied anatomy and Physiology of the nervous system

Applied anatomy and Physiology of the nervous system

REVIEW OF THE ANATOMY AND PHYSIOLOGY OF NERVOUS SYSTEM

Anatomy of the Nervous System

The nervous system can be separated into parts based on structure and on function:

Structurally, it’s organized into the central nervous system (CNS) and the peripheral nervous system (PNS). 

The CNS consists of the brain and spinal cord, both of which originate in the embryo. The PNS comprises all neural structures outside the CNS, connecting it to the rest of the body. These structures develop from neural crest cells and as extensions of the CNS itself. The PNS includes spinal and cranial nerves, visceral nerves and plexuses, and the enteric nervous system.

Functionally, the nervous system is divided into somatic and visceral components. The somatic nervous system (from the Greek ‘soma,’ meaning body) innervates structures derived from somites, such as skin and most skeletal muscle. 

It’s primarily responsible for receiving and responding to external environmental information. The visceral nervous system (from the Greek ‘viscera,’ meaning guts) innervates organ systems and other visceral elements like smooth muscle and glands throughout the body. It mainly detects and responds to information about the body’s internal environment. The neuron, with its cell body, axon, and synapse, is the functional unit of the entire nervous system.

Structural Division:
  • Central Nervous System (CNS): Composing the brain and spinal cord.
  • Peripheral Nervous System (PNS): Includes structures outside the CNS connecting it to the body.
Functional Division:
  • Somatic Part: Innervates structures from somites (skin, skeletal muscles). Responds to external environmental stimuli.
  • Visceral Part: Innervates organ systems, smooth muscles, and glands. Detects and responds to internal environmental stimuli.
Structure of a neuron

applied neuron structure

FUNCTIONS OF NEURON STRUCTURES
  • Nucleus – controls the entire neuron.
  • Dendrite – receives stimulus and carries its impulses toward the cell body.
  • Cell Body (soma) – has a nucleus & cytoplasm. It acts as a factory of the neuron. It produces all protein for the dendrites and neurotransmitters.
  • Axon – fiber which carries impulses away from the cell body i.e it forms a conduction region for the neuron.
  • Schwann Cells/ neurolemmocyte – cells which produce myelin or fat layer in the Peripheral Nervous System (axon maintenance and regeneration) It’s a glial cell that wraps the nerve fibre in PNS.
  • Myelin sheath – dense lipid layer which insulates the axon ( makes the axon look gray) It speeds-up nerve transmission.
  • Node of Ranvier – gaps or nodes in the myelin sheath. They speed up nerve transmission.
  • Axon terminals – form junctions with other cells.
There are three types of Neurons
  • Sensory neurons – bring messages to CNS.
  • Motor neurons – carry messages from CNS.
  • Interneurons – between sensory & motor neurons in the CNS.
applied sensory neuron
applied motor neuron

Neuron – Functional Unit:

  • Composed of nucleus, dendrites, cell body (soma), axon, Schwann cells, myelin sheath, Node of Ranvier, and axon terminals.
  • Three types: sensory neurons (to CNS), motor neurons (from CNS), and interneurons (between sensory and motor neurons in CNS).

Other Nervous System Cells:

  • Satellite Cells: Surround neuron cell bodies in ganglia. Maintain a micro-environment and provide insulation.
  • Ependymal Cells: Line CNS cavities, secrete cerebrospinal fluid, and form choroid plexuses.
  • Oligodendrocytes: Wrap around CNS neurons to produce myelin sheath.
  • Astrocytes: Glial cells in the CNS. Anchor neurons to blood vessels and form the blood-brain barrier.
  • Microglia: Monocytes in the nervous system. Move to damaged tissue for phagocytosis.

CENTRAL NERVOUS SYSTEM

Brain Anatomy & Physiology.

applied anatomy of the brain
Cerebrum:
  • Largest brain structure with frontal, temporal, parietal, and occipital lobes.
  • Divided into hemispheres by the longitudinal cerebral fissure.
  • Cerebral cortex (gray matter) and subcortical white matter.
  • Responsible for memory, sensory perception (pain, temperature, touch, sight, hearing, taste, smell), and control of skeletal muscle contractions.
Cerebellum:
  • Located behind the pons, below the occipital lobe.
  • Oval-shaped with hemispheres separated by vermis.
  • Contains gray and white matter.
  • Coordinates voluntary muscle movement, maintains posture and balance, and contributes to learning and language processing.
Brain Stem (Midbrain and Hindbrain – Pons & Medulla Oblongata):
  • Midbrain surrounds the cerebral aqueduct, connecting cerebrum and pons.
  • Pons, in front of the cerebellum, have nuclei and nerve fibers.
  • Medulla oblongata extends from the pons, continuous with the spinal cord, containing gray and white matter.
  • Midbrain acts as a relay station for ascending and descending nerve fibers, connecting cerebrum with lower brain fibers and spinal cord.
  • Pons collaborates with the medulla to control respiration.
  • Medulla oblongata controls respiration, cardiovascular function, and reflexes (vomiting, coughing, sneezing, swallowing). 
Diencephalon (Thalamus, Hypothalamus):
  • Connects cerebrum and midbrain.
  • Houses thalamus (gray and white matter masses) and hypothalamus (below thalamus, connected to pituitary gland).

Thalamus

  • Relays and distributes impulses from various brain parts to the cerebral cortex.
  • Plays a role in memory processing.

Hypothalamus

  • Controls the autonomic nervous system.
  • Regulates appetite, thirst, body temperature, water balance, emotional reactions, and sexual behavior.
  • Influences sleeping and waking cycles through melatonin from the pineal gland.
  • Secretes ADH (antidiuretic hormone) and oxytocin.

Anatomy of the Spinal Cord

  • Cylindrical shape with circular to oval cross-section and a central canal.
  • Comprises 31 pairs of spinal nerves, each with sensory (dorsal root) and motor (ventral root) fibers.

Physiology of the Spinal Cord:

Spinal cord provides communication between brain and the peripheral nerves. Tracts of white matter of the spinal cord carry sensory impulses to the brain and motor impulses from the brain to the skeletal muscles.

The grey matter of the spinal cord is a site of integration of reflexes which is rapid involuntary action in relation to a particular stimulus.

  • Facilitates communication between the brain and peripheral nerves.
  • White matter tracts carry sensory impulses to the brain and motor impulses from the brain to skeletal muscles.
  • Grey matter serves as the site for reflex integration, rapid involuntary actions in response to stimuli.
cross section of the spinal cord
spinal cord

Meninges:

Three connective tissue coverings surrounding and protecting the brain and spinal cord.

  • Dura Mater: Thickest and outermost layer, continuous with cranial dura mater. The spinal dura mater is continuous with the cranial dura mater at the foramen magnum of the skull and is the outermost meningeal membrane. In the cranial cavity, one layer of the dura mater is fused to the bone and represents the periosteum, but the spinal dura mater is separated from the bones of the vertebral canal by an extradural space. Inferiorly, the Dural sac dramatically narrows at the level of the lower border of vertebra SII and forms an investing sheath for the pial part of the filum terminale of the spinal cord. The dural part of the filum terminale attaches to the posterior surface of the vertebral bodies of the coccyx.
  • Arachnoid Mater: Thin, delicate membrane against the internal surface of the dura mater. This is a thin delicate membrane against, but not adherent to, the deep surface of the dura mater. It is separated from the pia mater by the subarachnoid space. The arachnoid mater ends at the level of vertebra SII. The sub-arachnoid space contain CSF.
  • Pia Mater: Adherent to the brain and spinal cord, extends into the anterior median fissure, and forms the denticulate ligament. It extends into the anterior median fissure and reflects as sleeve-like coating onto posterior and anterior rootlets and roots as they cross the subarachnoid space. As the roots exit the space, the sleeve-like coatings reflect onto the arachnoid mater. On each side of the spinal cord, a longitudinally oriented sheet of pia mater (the denticulate ligament) extends laterally from the cord toward the arachnoid and dura mater. Because the subarachnoid space can be accessed in the lower lumbar region without endangering the spinal cord, it is important to be able to identify the position of the lumbar vertebral spinous processes. The LIV vertebral spinous process is level with a horizontal line between the highest points on the iliac crests. In the lumbar region, the palpable ends of the vertebral spinous processes lie opposite their corresponding vertebral bodies. The subarachnoid space can be accessed between vertebral levels LIII and LIV and between LIV and LV without endangering the spinal cord.
cranial nerves

PERIPHERAL NERVOUS SYSTEM

CRANIAL NERVES and ASSESSMENT

In a clinical practice, it’s very important for the nurse to know the basic cranial nerves, there location and function. Below are the major cranial nerves in the body.

Olfactory Nerve (I):

  • Function: Smell.
  • Assessment: Identify different smells with eyes closed.

Optic Nerve (II):

  • Function: Vision.
  • Assessment: Visual test and examination with a special light.

Oculomotor Nerve (III):

  • Function: Pupil size and certain eye movements.
  • Assessment: Pupil examination with light, eye movement in various directions.

Trochlear Nerve (IV):

  • Function: Eye movement.
  • Assessment: Eye movement evaluation.

Trigeminal Nerve (V):

  • Function: Face sensation, inside mouth sensation, and chewing.
  • Assessment: Touch face, observe biting down.

Abducens Nerve (VI):

  • Function: Eye movement.
  • Assessment: Follow light or finger for eye movement.

Facial Nerve (VII):

  • Function: Face muscle movement and taste.
  • Assessment: Identify tastes, smile, move cheeks, show teeth.

Acoustic Nerve (VIII):

  • Function: Hearing.
  • Assessment: Hearing test.

Glossopharyngeal Nerve (IX):

  • Function: Taste and swallowing.
  • Assessment: Identify tastes on the back of the tongue, test gag reflex.

Vagus Nerve (X):

  • Function: Swallowing, gag reflex, taste, and part of speech.
  • Assessment: Swallowing, elicit gag response with a tongue blade.

Accessory Nerve (XI):

  • Function: Shoulder and neck movement.
  • Assessment: Turn head side to side against resistance, shrug shoulders.

Hypoglossal Nerve (XII):

  • Function: Tongue movement.
  • Assessment: Stick out tongue, speak.

 FIND THE REST OF THE ASSESSMENT BY CLICKING HERE

Spinal Nerves

Spinal nerves, like most nerves, contain both sensory and motor fibers. They are named and numbered according to the region of the vertebral column from which they originate: 

  • 8 cervical nerves (C1-C8), 12 thoracic nerves (T1-T12), 
  • 5 lumbar nerves (L1-L5), 
  • 5 sacral nerves (S1-S5), and 
  • 1 coccygeal nerve. 

Nerve C1 emerges between the cranium and the atlas (first cervical vertebra). All other spinal nerves emerge below the vertebra (or former vertebra, in the case of the sacrum) corresponding to their number.

A plexus is a network of interconnected nerve fibers that recombine to form new, named peripheral nerves.

Dermatomes are areas of skin and muscle innervated by specific spinal nerves. A dermatome map (as shown in the figure) is a valuable diagnostic tool. It helps determine the origin of somatic pain, numbness, or tingling, especially when these symptoms result from pressure or inflammation of the spinal cord or nerve roots.

  • Dermatomes are somatic or musculocutaneous areas served by fibers from specific spinal nerves.
  • Dermatome map aids in diagnosing somatic pain, numbness, tingling caused by spinal cord or nerve root pressure or inflammation.

Myotome:

  • Region of skeletal muscle innervated by a single nerve or spinal cord level.
  • Most muscles receive input from multiple spinal cord levels.

Applied anatomy and Physiology of the nervous system Read More »

Want notes in PDF? Join our classes!!

Send us a message on WhatsApp
0726113908

Scroll to Top
Enable Notifications OK No thanks

Terms and Conditions - Privacy Policy